Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
40761995	-liik.pr	% (—)	1200	3775	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Procreative management

1039

128

71.80

307.65

3.4

1.7

—

Persons encountering health services in circumstances related to reproduction

1045

129

56.30

307.65

3.4

1.7

—

Male infertility

265

304

9.86

216.03

4.2

3.1

—

Factors influencing health status and contact with health services

136

16.34

100.35

3.0

1.7

—

Diseases of male genital organs

354

801

2.24

37.37

3.7

2.9

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

7.18

30.47

1.6

3.2

—

Liquid cancers, helper endpoint

151

4.34

28.52

1.7

3.2

—

Secondary and unspecified malignant neoplasm of lymph nodes

9.27

28.27

1.7

3.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

119

4.89

26.63

1.6

3.1

—

Genitourinary diseases

290

700

2.08

25.90

3.7

2.8

—

Malignant neoplasm of testis

5.89

24.79

1.6

3.1

—

Secondary uncertain malignant neoplasm

7.77

24.64

1.7

3.0

—

Malignant neoplasm of testis, including Hilmo

5.70

24.60

1.6

3.2

—

Non-seminoma of testis, including Hilmo

10.14

23.45

1.3

3.2

—

Hodgkin lymphoma, hilmo

8.42

21.45

1.9

2.9

—

Non-Hodgkin lymphoma, all, including Hilmo

8.47

21.00

1.7

3.2

—

Malignant neoplasm

168

430

2.32

20.37

2.0

3.4

—

Solid cancers, helper endpoint

157

390

2.38

20.23

2.0

3.4

—

Any event in cancer register

169

448

2.22

18.74

2.0

3.4

—

Malignant neoplasm, wide definition for exclusion

179

497

2.11

17.58

2.0

3.5

—

Diabetes, insulin treatment (Kela reimbursement)

926

0.36

13.52

2.6

3.3

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

913

0.36

13.47

2.6

3.3

—

Diabetes medication

954

0.38

13.26

2.7

3.3

—

Neoplasms

278

899

1.64

12.35

2.5

3.4

—

malignant neoplasm of male genital organs

3.35

12.33

1.5

3.3

—

Other soft tissue disorders, not elsewhere classified

937

0.41

12.04

2.6

3.2

—

Diabetes mellitus

974

0.43

11.96

2.7

3.3

—

Diabetes, varying definitions

974

0.43

11.88

2.7

3.3

—

Type 2 diabetes

736

0.36

11.19

2.4

3.4

—

Abnormalities of breathing

941

0.44

10.92

3.2

—

Exposure to unspecified factor

223

976

1.65

10.76

3.1

—

Malignant neoplasm of brain

5.62

10.71

1.6

3.5

—

Nerve, nerve root and plexus disorders

790

0.39

10.69

3.7

3.2

—

Asthma/COPD (KELA code 203)

1077

0.44

10.68

3.3

3.2

—

Personal history of malignant neoplasm

8.52

10.52

1.9

2.8

—

Kela-code for severe mental illness

817

0.26

10.34

3.2

—

Schizophrenia

437

0.16

10.33

3.0

3.3

—

Enlarged lymph nodes

186

2.75

10.24

1.9

3.2

—

Schizophrenia or delusion

820

0.27

10.08

2.9

3.2

—

Schizophrenia, schizotypal and delusional disorders

820

0.27

10.08

2.9

3.2

—

Unspecified mental disorder

882

0.29

10.05

3.3

3.2

—

Schizophrenia or delusion, excluding more controls

809

0.27

10.02

2.9

3.2

—

Hypertension, essential

665

0.38

9.89

3.1

3.4

—

Other medical care

239

2.41

9.68

2.3

3.0

—

Malignant neoplasm of eye, brain and central nervous system

5.05

9.57

1.6

3.4

—

977

0.40

9.18

2.9

3.2

—

Hypertension

730

0.43

9.18

3.0

3.3

—

General examination and investigation of persons without complaint and reported diagnosis

683

0.43

9.15

2.7

3.2

—

934

0.38

9.14

2.6

3.2

—

Non-follicular lymphoma

7.73

9.11

1.7

3.0

—

Hypertensive diseases

732

0.44

8.99

2.9

3.4

—

Special screening examination for infectious and parasitic diseases

155

666

1.72

8.92

2.9

3.3

—

Finngen Rheumatological endpoints

895

0.49

8.79

2.8

3.2

—

Use of hypnotics and sedatives

808

0.48

8.53

3.1

3.4

—

Seminoma of testis

5.10

8.47

2.0

3.4

—

Mental and behavioural disorders due to psychoactive substance use

1073

0.44

8.29

2.5

3.2

—

Diseases of oesophagus, stomach and duodenum

832

0.48

8.29

3.2

—

Chronic lower respiratory diseases

116

1082

0.57

8.14

3.0

3.2

—

Pain in limb

732

0.43

8.02

2.7

3.2

—

Other diseases of intestines

101

1039

0.55

8.02

3.3

3.1

—

Polyarthropathies

553

0.35

8.00

3.4

3.3

—

Other (not insulin) diabetes medications

565

0.39

8.00

2.4

3.3

—

Seminoma of testis, including Hilmo

4.61

7.99

1.9

3.1

—

Substance abuse

1057

0.44

7.96

2.5

3.2

—

Benzodiazepine use

960

0.50

7.77

3.1

3.3

—

Type 2 diabetes, definitions combined, including avohilmo

579

0.41

7.70

2.3

3.4

—

Hypertensive diseases (excluding secondary)

683

0.46

7.68

3.0

3.4

—

Routine general health check-up of defined subpopulation

6.23

7.56

2.6

3.2

—

Alcohol use disorder, Swedish definition

853

0.41

7.51

2.9

3.3

—

Other and unspecified nonorganic psychotic disorders

660

0.30

7.49

3.1

—

Malignant neoplasm of brain, including Hilmo

3.92

7.43

1.6

3.1

—

Mental and behavioural disorders due to alcohol

881

0.41

7.27

2.6

3.3

—

Substance abuse, excluding more controls

923

0.46

7.21

2.5

3.2

—

Other heart diseases, wide

955

0.55

7.04

3.6

3.1

—

Type 2 diabetes, wide definition

422

0.32

7.02

2.5

3.1

—

Autoimmune diseases

124

1042

0.60

6.96

3.2

3.1

—

Lower back pain or/and sciatica

969

0.55

6.88

2.7

3.3

—

Other specific joint derangements/joint disorders

894

0.53

6.75

3.0

3.2

—

Other intervertebral disc disorders

706

0.49

6.74

3.6

3.4

—

Sleep apnoea

946

0.55

6.74

3.2

3.3

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

994

0.55

6.67

3.6

3.1

—

Triptan medication for migraine, single purchase ok

994

0.55

6.67

3.6

3.1

—

Hard cardiovascular diseases

454

0.38

6.65

3.1

3.2

—

Type 2 diabetes, strict (exclude DM1)

540

0.43

6.64

2.4

3.3

—

Insulin medication

742

0.43

6.62

3.1

3.3

—

Type 2 diabetes, definitions combined

539

0.44

6.62

2.4

3.3

—

Low back pain

805

0.50

6.43

2.4

3.3

—

Biguanides

490

0.41

6.37

2.5

3.3

—

Any mental disorder

113

932

0.61

6.31

3.2

—

Statin medication

897

0.58

6.20

3.2

3.3

—

Hypothyroidism (congenital or acquired)

430

0.41

6.11

3.0

3.5

—

Caries of enamel

200

983

1.47

6.10

2.9

3.2

—

Diarrhoea and gastroenteritis of presumed infectious origin

203

913

1.47

6.05

3.0

3.2

—

Brain astrocytoma, including Hilmo

15.79

5.98

1.8

4.0

—

Brain astrocytoma

15.79

5.98

1.8

4.0

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

7.27

5.92

2.2

3.6

—

Hypothyroidism, levothyroxine purchases

415

0.41

5.88

3.1

3.5

—

Hypothyroidism and >3 levothyroxin purchases

415

0.41

5.88

3.1

3.5

—

Cardiac arrhythmias

669

0.50

5.78

3.6

3.3

—

Other antidepressants

116

949

0.63

5.73

3.2

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

479

0.29

5.71

2.7

3.2

—

Substance use, excluding alcohol

569

0.35

5.69

2.0

3.3

—

Pain in joint

704

0.52

5.69

2.8

3.2

—

Personality disorders, excluding more controls

522

0.32

5.65

3.1

3.3

—

Antihypertensive medication - note that there are other indications

118

989

0.63

5.62

3.4

3.1

—

Alcohol use disorder, ICD-based

668

0.40

5.62

2.3

3.3

—

Persons encountering health services in other circumstances

563

0.35

5.61

2.8

3.1

—

Other heart diseases

708

0.52

5.60

3.6

3.3

—

Shoulder lesions

439

0.43

5.47

4.2

3.3

—

Insulin, combination of fast acting with intermediate-acting or long-acting

743

0.47

5.44

3.1

3.3

—

Tramadol

634

0.52

5.37

2.7

3.5

—

Bleeding

627

0.49

5.37

3.0

3.2

—

Artrosis, including avohilmo

615

0.54

5.32

3.0

3.4

—

Type of accident

425

0.28

5.24

2.8

3.2

—

Emergency coronary revascularization (for ACS)

336

0.36

5.24

3.4

3.0

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

713

0.45

5.22

2.6

3.3

—

Dyspnoea

522

0.44

5.21

3.5

3.2

—

Disorders of choroid and retina

532

0.45

5.21

3.0

3.3

—

Psychiatric diseases

110

870

0.63

5.21

3.0

3.2

—

Percutaneous Coronary Intervention

328

0.35

5.20

3.5

3.0

—

Autoimmune diseases excluding thyroid diseases

125

1042

0.65

5.12

3.2

3.1

—

Ischemic heart diseases

380

0.41

5.10

3.1

3.0

—

Brain glioblastoma and astrocytoma

8.44

5.07

1.7

4.1

—

Intracranial trauma

889

0.58

5.05

2.9

3.1

—

Oxicams

173

0.26

5.04

3.5

3.2

—

Major coronary heart disease event

353

0.39

5.02

3.4

3.0

—

Sleep apnoea, including avohilmo

105

1023

0.63

5.02

3.6

3.2

—

Soft tissue disorders

135

1041

0.67

4.99

3.1

3.2

—

Oral corticosteroids

892

0.62

4.99

3.2

—

Coronary revascularization (ANGIO or CABG)

330

0.37

4.99

3.4

3.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

643

0.52

4.98

3.1

3.2

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

702

0.54

4.98

3.3

3.2

—

Insulin, fast-acting or short human

658

0.44

4.94

3.3

—

Insulin, fast-acting

656

0.44

4.90

3.3

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

452

0.33

4.89

3.1

3.2

—

Inflammatory bowel disease treatment related agents

124

1047

0.66

4.84

3.1

3.2

—

Alcohol abuse, main dg, excluding more controls

290

0.28

4.76

3.6

3.2

—

Dorsalgia

121

979

0.66

4.72

2.8

3.2

—

Medicines for HER+ breast cancer

4.44

4.72

4.3

2.9

—

Spondylopathies

432

0.47

4.72

2.6

3.4

—

Personality disorders

474

0.36

4.70

3.1

3.3

—

Exclusions for E4_PCOS_CONSORTIUM

389

0.43

4.65

2.5

3.2

—

Periodontitis

827

0.60

4.64

3.3

—

Asthma, including avohilmo

128

1068

0.67

4.63

3.0

3.2

—

Autoimmune diseases excluding thyroid diseases, strict definition

127

1034

0.67

4.60

3.2

3.1

—

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

14.12

4.58

2.4

3.0

—

Constipation

445

0.45

4.57

3.2

3.1

—

Chronic periodontitis, including avohilmo

823

0.60

4.53

3.3

—

Disorders of gallbladder, biliary tract and pancreas

447

0.48

4.50

3.0

3.1

—

Disorders of the thyroid gland

505

0.50

4.50

2.8

3.3

—

Mood disorders, excluding more controls

101

932

0.65

4.49

3.2

—

Migraine

511

0.46

4.39

3.8

3.2

—

Benign neoplasms

121

991

0.67

4.39

3.3

3.2

—

Insulin, intermediate and long-acting

725

0.51

4.34

3.1

3.3

—

Type 1 diabetes

664

0.48

4.34

3.2

3.3

—

Insulin, fast-acting (human)

437

0.36

4.28

3.3

—

Metabolic disorders

701

0.60

4.27

3.0

3.3

—

Used for control exclusion in common control thyroid runs

139

1012

0.69

4.25

3.1

—

Type 1 diabetes, wide definition, subgroup 1

617

0.47

4.23

3.3

—

Other anxiety disorders

898

0.59

4.21

3.1

—

Sub-endpoint used in defining T1D endpoints

647

0.49

4.21

3.2

3.3

—

Chronic apical periodontitis

126

1047

0.68

4.19

3.5

3.1

—

Pain in throat and chest

103

936

0.66

4.17

3.1

3.2

—

Malignant neoplasm of respiratory system and intrathoracic organs

5.39

4.09

2.1

3.0

—

Other retinal disorders

445

0.45

4.08

3.4

3.2

—

Type 1 diabetes, wide definition

621

0.48

4.07

3.2

3.3

—

Hypothyroidism, strict autoimmune

327

0.42

3.97

3.0

3.2

—

Neurological diseases

131

945

0.70

3.96

3.3

3.1

—

Poisoning by medicine

391

0.36

3.95

1.9

3.3

—

Gastro-oesophageal reflux disease

497

0.47

3.95

3.6

3.2

—

Suicide or other Intentional self-harm

405

0.37

3.94

3.1

3.3

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

405

0.37

3.94

3.1

3.3

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

415

0.49

3.92

3.0

3.2

—

Specific personality disorders

359

0.33

3.91

2.5

3.3

—

Hypothyroidism, other/unspecified

412

0.49

3.82

3.0

3.2

—

Poisoning by drugs, medicaments and biological substances

425

0.40

3.77

2.1

3.2

—

Examination and observation for other reasons

662

0.63

3.70

3.3

3.2

—

ILD medications: prednisolone, methylprednisolone, prednisone

121

970

0.70

3.70

3.0

3.2

—

Arthrosis

442

0.56

3.69

2.5

3.4

—

Asthma (diagnoses ohter than nonallergic)

961

0.64

3.67

2.8

3.1

—

Depression

110

1078

0.69

3.62

3.1

—

Acute alcohol intoxication

359

0.36

3.61

2.8

3.3

—

Medical observation and evaluation for suspected diseases and conditions

683

0.66

3.61

2.5

3.2

—

L02BG Aromatase inhibitors

4.40

3.61

5.0

2.3

—

Diabetic maculopathy, excluding more controls

218

0.27

3.60

3.7

3.0

—

Viral hepatitis, IBD co-morbidity

232

0.30

3.59

2.7

3.5

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

312

0.32

3.57

2.2

3.2

—

Malignant neoplasm of other connective and soft tissue

7.83

3.56

1.6

4.2

—

Alcohol abuse, main dg

247

0.32

3.55

3.6

2.9

—

Abnormalities of heart beat

333

0.35

3.52

2.8

3.1

—

L02BA Anti-estrogens

10.01

3.49

3.2

3.8

—

Toxic effects of substances chiefly nonmedicinal as to source

211

0.28

3.47

3.7

3.1

—

Other symptoms and signs involving the nervous and musculoskeletal systems

350

0.37

3.44

1.7

3.3

—

Disorders of lens

155

0.32

3.43

1.9

2.9

—

Other disorders of ear

529

0.58

3.41

3.5

3.2

—

Malignant neoplasm of mesothelium and soft tissue

5.74

3.34

1.6

3.9

—

Follow-up examination after treatment for conditions other than malignant neoplasms

359

0.50

3.33

2.8

3.2

—

Mood disorders

119

1078

0.71

3.28

3.2

3.1

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

309

0.46

3.27

3.0

3.1

—

Acute alcohol intoxication, ICD10

341

0.38

3.27

2.8

3.2

—

Diffuse large B-cell lymphoma, helper endpoint

8.60

3.26

2.2

4.6

—

Diffuse large B-cell lymphoma, including Hilmo

8.60

3.26

2.2

4.6

—

Diffuse large B-cell lymphoma

8.60

3.26

2.2

4.6

—

Other arrhythmias

435

0.52

3.26

4.2

3.2

—

Mood [affective] disorders

119

1078

0.71

3.25

3.2

3.1

—

ILD medications

141

1043

0.73

3.24

3.1

3.2

—

Autoimmune diseases related-to ILD

1053

0.67

3.23

3.1

3.2

—

Other special examinations and investigations of persons without complaint or reported diagnosis

683

0.68

3.21

3.4

3.2

—

Triptan medication for migraine, min. 3 purchases

457

0.53

3.20

3.1

3.2

—

Acute and transient psychotic disorders

233

0.34

3.16

2.1

3.2

—

Erysipelas

629

0.61

3.14

3.0

3.4

—

Non-seminoma of testis

5.33

3.12

1.4

3.3

—

Asthma (only as main-diagnosis), excluding more controls

662

0.66

3.12

3.1

3.2

—

Other and unspecified dermatitis

390

0.44

3.12

2.9

3.2

—

Gender identity disorders

3.72

3.10

1.4

2.8

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

705

0.60

3.09

3.3

3.1

—

Lumbar disc prolapse

588

0.60

3.04

3.4

—

Selective serotonin reuptake inhibitors

135

957

0.74

3.02

2.9

3.1

—

Injuries to the thorax

531

0.53

3.00

2.5

3.3

—

Asthma, excluding more controls

662

0.68

3.00

3.0

3.2

—

Bipolar affective disorders

341

0.41

2.99

2.1

3.3

—

Symptoms and signs involving the nervous and musculoskeletal systems

437

0.48

2.98

2.0

3.2

—

Asthma (only as main-diagnosis)

663

0.67

2.98

3.1

3.2

—

Implicit Sepsis

470

0.56

2.97

2.9

3.2

—

Disorders of lipoprotein metabolism and other lipidaemias

441

0.59

2.93

3.5

3.3

—

Other disorders of skin and subcutaneous tissue

422

0.50

2.92

3.3

3.2

—

Carpal tunnel syndrome

260

0.37

2.92

3.5

3.2

—

Hyperkinetic disorders, excluding more controls

477

0.52

2.90

2.7

3.1

—

Symptoms and signs involving the circulatory and respiratory systems

149

993

0.75

2.90

3.1

3.2

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

321

0.40

2.90

1.4

3.3

—

Headache

770

0.65

2.90

3.2

—

Persons with potential health hazards related to communicable diseases

807

0.63

2.89

2.7

3.2

—

Non-Hodgkin lymphoma, all

6.68

2.87

1.5

3.4

—

Coxibs

359

0.59

2.82

3.0

2.9

—

Asthma

663

0.70

2.82

3.0

3.2

—

Problems related to lifestyle

191

0.31

2.78

2.0

3.2

—

Recurrent or chronic depression

638

0.65

2.77

3.6

3.2

—

Heart failure and antihypertensive medication

125

0.31

2.76

4.5

2.8

—

Asthma, hospital admissions , main diagnosis only

1049

0.70

2.76

3.1

3.2

—

Disorders of thyroid, IBD co-morbidities

132

0.32

2.74

2.5

3.3

—

Inguinal hernia

907

0.71

2.74

2.8

3.2

—

Other necrotizing vasculopathies

4.22

2.67

2.3

3.6

—

Otitis media, unspecified

199

0.37

2.67

1.9

2.6

—

Other joint disorders

144

999

0.76

2.64

3.0

3.2

—

Disorders of psychological development

482

0.56

2.62

2.7

3.0

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.66

2.62

2.3

2.9

—

Other dorsopathies, not elsewhere classified

144

989

0.76

2.60

2.9

3.2

—

Dermatitis

504

0.55

2.60

3.2

—

Dislocation, sprain and strain of joints and ligaments of knee

137

955

1.32

2.59

3.2

3.1

—

Transport accidents

100

619

1.39

2.58

3.1

—

Asthma (mode)

665

0.71

2.58

3.0

3.2

—

Concussion

861

0.69

2.56

2.9

3.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

320

0.55

2.54

2.6

3.3

—

Special screening examination for other diseases and disorders

163

0.31

2.54

4.6

3.1

—

Disorders of eyelid, lacrimal system and orbit

479

0.60

2.53

3.5

3.1

—

Diseases of liver

274

0.40

2.53

2.9

—

Other diseases of urinary system

440

0.64

2.53

3.0

3.1

—

Oxycodone

141

1.86

2.52

2.0

3.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

546

0.66

2.52

2.9

3.3

—

Mental and behavioural disorders due to sedatives or hypnotics

182

0.33

2.52

1.5

3.1

—

Alcohol dependence

368

0.49

2.49

2.6

3.3

—

Intestinal infectious diseases

172

1022

1.28

2.47

3.1

—

Erysipelas

463

0.57

2.46

2.9

3.3

—

Intracranial injury

887

0.68

2.46

3.0

3.1

—

Disorders of adult personality and behaviour

509

0.57

2.45

2.7

3.3

—

Allergic asthma (mode), excluding more controls

535

0.58

2.44

2.7

3.2

—

Allergic asthma (mode)

534

0.59

2.43

2.7

3.2

—

Biological medication for rheuma

351

0.48

2.43

4.0

3.1

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

0.00

2.42

0.0

2.8

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

680

0.69

2.41

2.8

3.3

—

Infections with a predominantly sexual mode of transmission

521

1.44

2.41

2.6

3.3

—

Episodal and paroxysmal disorders

155

1014

0.78

2.41

3.1

3.2

—

Viral hepatitis

204

0.39

2.41

2.5

3.1

—

Migraine without aura

207

0.39

2.39

4.5

2.9

—

Other condition

208

0.38

2.39

2.4

2.9

—

Asthma, unspecified (mode), excluding more controls

408

0.59

2.38

2.5

3.2

—

Other neurological diseases

337

0.54

2.37

3.2

3.1

—

Ulcerative colitis

452

0.55

2.36

4.3

3.2

—

Asthma, unspecified (mode)

408

0.59

2.33

2.5

3.2

—

Dermatitis and eczema

132

1065

0.77

2.33

3.0

3.2

—

All-cause Heart Failure

123

0.34

2.33

4.7

2.9

—

Other viral hepatitis

201

0.40

2.29

2.5

3.1

—

Diverticular disease of intestine

186

0.45

2.28

3.5

3.1

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

381

0.52

2.26

4.0

3.2

—

Contact with and exposure to communicable diseases

663

0.64

2.21

2.6

3.2

—

Heart failure, strict

131

0.38

2.20

4.1

2.9

—

Disorders of synovium and tendon

465

0.60

2.20

4.0

3.2

—

Mental and behavioural disorders due to cannabinoids

213

0.42

2.20

2.6

3.3

—

Organic, including symptomatic, mental disorders

111

0.32

2.18

3.0

—

Persistent mood disorders

210

0.43

2.18

3.1

—

Tumor necrosis factor alpha inhibitors

323

0.49

2.17

4.1

3.2

—

Type 1 diabetes, strict (exclude DM2)

425

0.56

2.16

3.2

3.3

—

STROKE

257

0.53

2.16

2.5

3.0

—

Cardiovascular diseases (excluding rheumatic etc)

137

1010

0.78

2.16

3.0

3.2

—

Hyperkinetic disorders

442

0.57

2.16

2.7

3.1

—

Psoriasis

295

0.47

2.15

2.1

3.0

—

Symptoms and signs involving the urinary system

524

0.65

2.15

2.3

3.2

—

Diseases of the skin and subcutaneous tissue

143

916

0.78

2.15

3.2

—

Papulosquamous disorders

348

0.52

2.14

2.5

3.1

—

Chronic viral hepatitis

183

0.38

2.14

2.7

3.1

—

Sleep disorders (combined)

149

992

0.79

2.13

3.1

3.2

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

710

0.67

2.12

3.3

3.2

—

Conductive and sensorineural hearing loss

322

0.59

2.11

3.5

3.1

—

All kidney diseases

695

0.72

2.10

2.9

3.2

—

Crushed, pushed or stepped on by crowd or human stampede

244

1.61

2.10

3.5

3.0

—

Heart failure,strict

127

0.39

2.08

4.1

2.9

—

Parasetamol

151

966

0.79

2.08

3.0

3.2

—

Neurological diseases, wide definition

570

0.73

2.07

3.3

3.2

—

Dissocial personality disorder

0.00

2.07

0.0

2.9

—

Strabismus

316

0.50

2.06

3.0

—

L04AX Other immunosuppressants

665

0.66

2.05

3.3

3.2

—

Other congenital malformations of circulatory system

4.02

2.04

2.5

2.9

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

599

0.64

2.04

3.3

3.1

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2.87

2.04

1.8

3.3

—

Continuous positive airway pressure

137

0.37

2.03

3.7

2.7

—

Other and unspecified myopathies

0.00

2.03

0.0

3.1

—

Heart failure, not strict

286

0.57

2.03

3.3

3.1

—

Necrosis of pulp, including avohilmo

849

0.70

2.00

3.4

3.2

—

Inflammatory bowel disease

589

0.64

2.00

3.7

3.2

—

Dorsopathies

158

1002

0.80

1.98

2.9

3.2

—

Other bacterial diseases

868

0.76

1.97

2.6

3.3

—

Anxiety (asthma-related co-morbidities)

100

1014

0.76

1.97

3.3

3.2

—

5-aminosalicylic acid

439

0.59

1.97

4.2

3.3

—

All anxiety disorders

101

1044

0.76

1.96

3.3

3.1

—

Other disorders starting during childhood or adolecense, excluding more controls

193

0.44

1.96

2.6

3.1

—

Other arthrosis

244

0.54

1.96

2.9

3.2

—

Type 1 diabetes, strict definition, subgroup 1

399

0.57

1.96

3.3

3.2

—

Type 1 diabetes, definitions combined

424

0.59

1.96

3.2

3.3

—

Gonarthrosis

194

0.53

1.95

1.7

3.1

—

Myopia

229

0.44

1.94

2.7

3.0

—

Bacterial infection, other or unspecified

360

1.43

1.94

2.1

3.2

—

Atrial fibrillation and flutter

228

0.54

1.94

3.1

—

Ulcerative colitis (strict definition, require KELA)

361

0.55

1.94

4.0

3.1

—

Malignant neoplasm of colon

3.75

1.93

3.8

3.4

—

Scabies

242

0.45

1.93

2.3

2.9

—

Noninfective enteritis and colitis

738

0.69

1.93

3.5

3.1

—

IBD patients in KELA-register

498

0.62

1.92

3.8

3.2

—

Cholelithiasis, broad definition with cholecystitis

253

0.56

1.92

3.2

3.1

—

Second line medication for Crohn's disease

726

0.69

1.92

3.3

3.2

—

Type 1 diabetes, strict definition

408

0.58

1.90

3.2

—

Inflammatory bowel disease, strict (require KELA)

496

0.62

1.90

3.8

3.2

—

Depression medications

596

0.75

1.89

3.1

3.4

—

Other acute lower respiratory infections

690

0.69

1.89

3.0

3.2

—

Irritable bowel syndrome

226

0.44

1.88

2.8

3.0

—

Disturbance of activity and attention

412

0.59

1.88

2.8

3.0

—

Artificial opening status

3.19

1.88

3.0

3.4

—

Malignant neoplasm of kidney, except renal pelvis

3.19

1.88

3.1

3.6

—

Malignant neoplasm of urinary organs

3.19

1.88

3.1

3.6

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

289

0.51

1.87

3.5

3.1

—

Periapical abscess

579

0.66

1.86

2.6

3.3

—

Care involving use of rehabilitation procedures

533

0.66

1.86

3.1

3.2

—

ILD medications: immunosuppressive drugs

887

0.73

1.86

3.3

3.2

—

Malignant neoplasm of colon, including Hilmo

2.86

1.86

3.9

3.3

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

355

0.56

1.84

4.0

3.2

—

Type1 diabetes, definitions combined, early onset

340

0.55

1.84

3.1

—

Ischaemic heart disease, wide definition

206

0.54

1.84

3.1

3.0

—

Other fall from one level to another

329

0.55

1.84

3.8

3.1

—

Other necrotizing vasculopathies (FG)

3.54

1.83

2.3

3.8

—

Malignant neoplasm of head and neck

4.17

1.82

1.6

2.8

—

Viral and other specified intestinal infections

666

0.69

1.82

3.4

3.1

—

Other specified/unspecified arthritis

222

0.45

1.81

2.8

3.0

—

Impacted teeth

575

0.68

1.80

3.7

3.0

—

Syncope and collapse

313

0.57

1.79

4.0

3.3

—

Glaucoma

146

0.41

1.79

3.4

3.0

—

Diseases of pulp and periapical tissues, including avohilmo

145

933

0.80

1.78

3.2

3.1

—

Other disorders of patella

167

0.42

1.78

4.1

3.2

—

Other chronic obstructive pulmonary disease, including avohilmo

128

0.39

1.77

2.8

3.0

—

Superficial injury of wrist and hand

401

0.60

1.77

3.1

3.2

—

Other arthritis (FG)

260

0.50

1.77

2.5

3.0

—

Codeine or tramadol medication

143

971

0.81

1.76

2.6

3.3

—

Rare circulating lymphoid malignancy, including Hilmo

3.34

1.74

1.7

2.8

—

Rotator cuff syndrome

261

0.58

1.74

3.3

3.0

—

Ethmoidectomy

137

0.36

1.74

5.6

3.0

—

Gonarthrosis [arthrosis of knee](FG)

197

0.56

1.72

1.7

2.9

—

Acute suppurative otitis media

867

0.74

1.72

3.0

3.2

—

Urethritis and urethral syndrome

3.86

1.71

4.2

2.8

—

Diseases of the musculoskeletal system and connective tissue

121

765

0.79

1.71

2.9

3.2

—

Unspecified fall

605

0.68

1.70

2.8

3.2

—

Pediculosis, acariasis and other infestations

269

0.52

1.70

2.6

2.9

—

Agranulocytosis

2.06

1.70

2.4

2.8

—

Endocrine, nutritional and metabolic diseases

160

990

0.82

1.69

2.7

3.2

—

Open wound of head

969

0.76

1.68

3.2

—

Invasive ventilation

0.00

1.68

0.0

2.9

—

Complications of surgical and medical care, not elsewhere classified

730

0.76

1.67

2.4

3.3

—

Anaemias

299

0.63

1.66

3.3

3.5

—

Bacterial infection, other or unspecified

324

1.42

1.66

2.2

3.2

—

Conduction disorders

121

0.40

1.66

3.3

2.8

—

Nutritional anaemias

158

0.43

1.65

5.0

2.8

—

Other strabismus

291

0.55

1.65

3.0

—

Other sexually transmitted chlamydial diseases

228

1.54

1.65

2.9

3.1

—

Other salmonella infections

2.45

1.64

2.6

2.9

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

149

0.40

1.64

1.2

3.1

—

Rheumatoid arthritis

117

0.38

1.63

5.4

3.3

—

Benign neoplasm: Skin, unspecified

3.58

1.61

2.8

3.0

—

Colorectal cancer

2.52

1.61

3.5

3.2

—

Superficial injury of thorax

188

0.48

1.61

2.8

3.0

—

Convulsions, not elsewhere classified

433

0.64

1.61

2.3

3.3

—

Mouth breathing

425

0.63

1.59

3.1

3.2

—

Mucosal proctocolitis

301

0.56

1.59

4.2

3.1

—

Gingival hyperplasia

2.70

1.58

1.7

2.8

—

Fracture of rib(s), sternum and thoracic spine

249

0.52

1.58

1.4

3.0

—

Embedded and impacted teeth

746

0.75

1.56

3.2

3.1

—

Other symptoms and signs involving cognitive functions and awareness

226

0.52

1.56

3.6

2.9

—

Nonorganic sleeping disorders, excluding more controls

349

0.60

1.55

2.8

3.2

—

Injury of eye and orbit

361

0.61

1.55

3.0

3.3

—

Hernia

124

1027

0.81

1.55

3.1

3.2

—

Intestinal infectious diseases

188

898

1.20

1.54

3.1

3.2

—

Other degenerative diseases of the nervous system

109

0.41

1.54

1.7

2.9

—

Other bacterial intestinal infections

168

1.61

1.54

2.9

—

Other diseases of liver

158

0.44

1.54

3.9

2.9

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

2.43

1.53

1.5

3.5

—

Speech and linguistic disorders, excluding more controls

373

0.63

1.53

2.9

3.0

—

Other bacterial diseases

124

971

0.81

1.53

2.6

3.3

—

Inflammatory diseases of prostate (prostatitis)

140

0.43

1.51

2.3

3.0

—

Covid-19 confirmed case

309

0.58

1.51

2.7

3.2

—

Cholelithiasis

240

0.60

1.51

3.2

3.0

—

Enterobiasis

2.87

1.50

2.8

2.5

—

Meniscus derangement

373

0.69

1.50

2.9

3.3

—

Other symptoms and signs involving general sensations and perceptions

0.00

1.50

0.0

2.8

—

Pervasive developmental disorders excl. Autism + Asperger

0.00

1.49

0.0

2.6

—

Alcoholic liver disease

0.00

1.49

0.0

3.0

—

Stroke, including SAH

178

0.53

1.49

2.1

2.8

—

Cerebrovascular diseases

235

0.60

1.49

2.0

3.1

—

Acetic acid derivatives and related substances

343

0.71

1.49

3.4

3.0

—

Cystitis

221

0.62

1.47

2.9

3.0

—

Urticaria and erythema

380

0.63

1.47

2.9

3.2

—

Artificial joint operation, meniscal resection

590

0.76

1.47

3.0

3.3

—

Stroke, excluding SAH

159

0.50

1.47

2.3

2.8

—

Undescended testis, unilateral

2.41

1.46

3.2

2.3

—

Exposure to other specified factors

140

1059

1.21

1.45

3.1

3.2

—

Panic disorder

279

0.57

1.44

2.6

3.2

—

Obstructive hydrocephalus

3.14

1.44

3.0

3.4

—

Myeloid leukaemia

3.14

1.44

1.6

3.3

—

Haemolytic anaemias

3.13

1.44

2.2

3.0

—

Dentofacial anomalies [including malocclusion]

932

0.79

1.43

3.1

3.2

—

Other and unspecified mood [affective] disorders

153

0.46

1.43

2.6

3.1

—

Ischaemic Stroke, excluding all haemorrhages

134

0.50

1.42

2.4

2.9

—

Cellulitis

302

0.60

1.41

2.4

3.2

—

COPD

115

0.43

1.41

2.5

2.9

—

Malaise and fatigue

313

0.64

1.40

3.3

3.4

—

Coronary atherosclerosis

136

0.51

1.40

3.3

2.8

—

Lymphoid leukaemia

2.42

1.39

1.4

2.5

—

Diagnoses used for exclusion with ILD

177

0.51

1.39

2.6

3.0

—

Adalimumab

179

0.50

1.39

2.9

3.0

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

2.42

1.39

3.1

3.4

—

Iron deficiency anaemia

137

0.43

1.39

4.0

3.1

—

Diseases of middle ear and mastoid

149

1015

1.20

1.38

3.0

3.2

—

Thoracic aortic aneurysm

1.94

1.38

4.2

3.1

—

Other chronic obstructive pulmonary disease

103

0.40

1.38

2.8

2.9

—

Psoriasis vulgaris

211

0.52

1.37

1.8

3.0

—

Family history of other conditions

2.62

1.37

3.7

3.0

—

Colorectal adenocarcinoma

2.60

1.36

3.2

3.5

—

Congenital malformations, deformations and chromosomal abnormalities

137

1047

1.21

1.35

3.1

3.2

—

Spondylopathies (FG)

222

0.54

1.34

2.9

3.1

—

Cholecystitis

0.00

1.34

0.0

3.0

—

Other and unspecified mental retardation

0.00

1.34

0.0

2.8

—

Alcohol-induced acute pancreatitis

0.00

1.34

0.0

2.9

—

Use of biperiden

0.00

1.33

0.0

3.0

—

Spondyloarthritis

234

0.55

1.33

3.5

3.1

—

Insomnia

120

1062

0.82

1.33

3.0

3.2

—

Arthropathies

167

1001

0.84

1.32

3.1

3.2

—

Other problems related to primary support group, including family circumstances

143

0.48

1.32

2.3

2.8

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

308

0.62

1.31

4.2

3.1

—

Mental disorders, not otherwise specified

148

0.47

1.31

2.9

3.0

—

Acute pancreatitis

146

0.48

1.31

3.1

2.9

—

Acute bronchitis

420

0.68

1.31

3.3

—

Sexual dysfunction

2.11

1.30

4.2

3.4

—

Internal derangement of knee

437

0.68

1.29

2.2

3.3

—

Sensorineural hearing loss

251

0.65

1.29

3.5

3.0

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

169

0.52

1.29

2.6

2.8

—

Persons encountering health services for specific procedures and health care

137

984

0.83

1.29

2.9

3.2

—

Nasal polyp

175

0.51

1.28

4.2

2.9

—

Malignant neoplasm of prostate, including Hilmo

2.97

1.27

1.2

3.6

—

Childhood asthma (age<16), excluding more controls

537

0.75

1.27

3.3

3.2

—

Childhood asthma (age<16)

537

0.75

1.27

3.3

3.2

—

Diarrhoea and gastroenteritis of presumed infectious origin

125

933

1.21

1.26

3.1

3.2

—

COPD, early/later onset

0.43

1.26

2.8

2.7

—

Fracture of lower leg, including ankle

773

0.77

1.26

3.6

3.1

—

Non-rheumatic valve diseases

185

0.58

1.26

4.6

2.8

—

Sleep disorders

121

1054

0.83

1.25

3.0

3.2

—

Visual disturbances and blindness

435

0.69

1.24

3.7

3.1

—

Other extrapyramidal and movement disorders in other diseases

118

0.42

1.24

3.8

3.0

—

L04AC Interleukin inhibitors

119

0.42

1.24

3.6

3.0

—

Urticaria

327

0.64

1.23

3.0

3.1

—

Valvular heart disease excluding rheumatic fever

193

0.60

1.23

4.9

2.8

—

Overexertion and strenuous or repetitive movements

155

1.55

1.22

2.4

3.2

—

Ulcerative colitis, NAS

265

0.60

1.22

4.7

2.9

—

Cutaneous abscess, furuncle and carbuncle

433

0.69

1.22

3.3

—

Family history of certain disabilities and chronic diseases leading to disablement

1.97

1.22

2.5

2.7

—

Budesonide

189

0.53

1.22

3.0

3.2

—

Hyperprolactinaemia

2.64

1.21

4.0

2.6

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

101

801

1.23

1.21

3.7

3.1

—

Injury of muscle and tendon at wrist and hand level

252

0.59

1.21

2.8

3.1

—

Anxiety disorders, excluding more controls

119

932

0.83

1.21

3.3

3.2

—

Pneumonias (Asthma/COPD co-morbidities)

130

1041

0.84

1.20

2.8

3.2

—

Persons encountering health services for specific procedures, not carried out

141

0.50

1.20

2.0

3.0

—

Reimbursement for rheumatic diseases

488

0.71

1.20

3.2

—

Acute pancreatitis (for exclusion)

141

0.50

1.20

3.1

2.9

—

Assault by bodily force

299

0.63

1.18

4.0

3.2

—

Other salmonella infections

2.31

1.18

2.7

2.9

—

Fall on same level

162

1036

0.85

1.18

3.1

3.2

—

Haemorrhage from respiratory passages

237

0.61

1.18

3.3

3.0

—

Renal tubulo-interstitial diseases

442

0.74

1.18

2.7

3.2

—

Other functional intestinal disorders

311

0.66

1.17

2.7

2.9

—

All pneumoniae

132

1048

0.84

1.17

2.8

3.2

—

Emotional disorders starting during childhood or adolecense, excluding more controls

123

0.47

1.17

3.8

2.9

—

Undescended testicle

2.02

1.16

3.5

2.3

—

Dermatitis due to substances taken internally

2.00

1.16

1.4

2.7

—

Accidental poisoning by and exposure to alcohol

0.00

1.16

0.0

3.0

—

Status epilepticus

0.00

1.16

0.0

3.0

—

Schizoid personality disorder

0.00

1.16

0.0

3.1

—

Synovial cyst of popliteal space [Baker]

0.00

1.16

0.0

2.8

—

Other encephalitis

0.00

1.16

0.0

3.0

—

Systemic atrophies primarily affecting the central nervous system

2.50

1.15

2.6

2.9

—

Cerebrovascular diseases (FINNGEN)

194

0.62

1.15

1.9

3.1

—

Paralytic strabismus

0.00

1.15

0.0

3.1

—

Allergic colitis

0.00

1.14

0.0

2.1

—

Conjunctivitis (acute, non atopic)

330

0.66

1.13

3.4

3.0

—

COPD, hospital admissions

0.43

1.12

2.8

2.7

—

Dialysis

2.01

1.12

3.0

2.7

—

Cerebral palsy and other paralytic syndromes

114

0.44

1.12

2.8

3.0

—

Visual disturbances

413

0.70

1.11

3.7

3.0

—

Transplanted organ and tissue status

119

1.60

1.11

2.2

2.9

—

Abnormal findings on examination of blood, without diagnosis

259

0.64

1.11

2.5

2.9

—

Codeine

141

901

0.85

1.10

2.6

3.3

—

Viral and other specified intestinal infections

812

0.79

1.09

3.2

3.1

—

Exposure to other and unspecified man-made environmental factors

2.39

1.09

1.4

3.1

—

Melanocytic naevi of trunk

104

1.64

1.09

3.1

—

Missing teeth due to accident, extraction or parodontitis

287

0.66

1.09

3.3

3.1

—

Other disorders starting during childhood or adolescence

160

0.56

1.08

2.6

2.8

—

Angina pectoris

0.48

1.08

2.8

3.1

—

Sulfasalazine

304

0.66

1.08

3.6

3.1

—

Other sexually transmitted chlamydial diseases

338

1.33

1.07

3.4

3.2

—

Effects of foreign body entering through natural orifice

502

0.74

1.07

3.5

3.2

—

Other and unspecified tonsillitis

743

0.80

1.06

3.7

3.1

—

Other disorders of urethra and urinary system

167

0.60

1.06

3.9

2.9

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

124

998

0.85

1.05

2.8

3.2

—

Lesion of lateral popliteal nerve

2.13

1.05

4.3

3.1

—

Disorders of refraction and accommodation

348

0.69

1.05

3.1

3.0

—

Gonarthrosis,primary

135

0.59

1.05

1.6

2.9

—

Other disorders of fluid, electrolyte and acid-base balance

116

0.49

1.05

3.3

2.9

—

Allergic conjunctivitis

102

827

1.20

1.05

3.7

3.1

—

Diseases of oral cavity, salivary glands and jaws

101

428

1.21

1.05

3.0

3.3

—

Zoster [herpes zoster]

300

1.35

1.04

3.1

2.9

—

Specific development disorders of speech and language

220

0.61

1.04

2.9

—

Nail disorders

125

0.48

1.04

1.8

3.1

—

Other predominantly sexually transmitted diseases, not elsewhere classified

314

1.34

1.04

2.6

3.2

—

Obesity related asthma

265

0.64

1.04

1.9

3.0

—

Speech and linguistic disorders

345

0.69

1.03

2.9

—

Other Crohn's disease

147

0.54

1.03

3.0

2.9

—

Malignant neoplasm of thyroid gland

2.27

1.03

2.4

3.1

—

Malignant neoplasm of thyroid gland, including Hilmo

2.27

1.03

2.4

3.1

—

Diseases of arteries, arterioles and capillaries

231

0.67

1.02

3.5

2.9

—

Deviated nasal septum

450

0.73

1.01

3.2

—

Other disorders of lacrimal gland

177

0.56

1.01

2.5

3.0

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

107

0.47

1.01

2.2

2.9

—

Other diseases of lip and oral mucosa

334

0.69

1.00

3.0

3.1

—

Arthropathic psoriasis

109

0.46

1.00

1.8

3.2

—

Migraine with aura and triptan purchases

109

0.46

1.00

4.6

2.7

—

659

0.78

1.00

2.8

3.1

—

Other noninfective gastroenteritis and colitis

274

0.66

1.00

2.9

—

Other CVD (FINNGEN)

0.00

0.99

0.0

3.4

—

Sciatica+with lumbago

392

0.73

0.99

3.1

3.5

—

Hyperlipidaemia, other/unspecified

121

0.53

0.99

3.6

2.7

—

Emotional disorders and disorders of social functioning with onset specific to childhood

129

0.53

0.99

3.4

2.7

—

Pedal cyclist injured in collision with motor vehicle

1.84

0.98

2.2

2.7

—

Congenital malformations of genital organs

1.64

0.98

3.1

2.3

—

Depression or dysthymia

100

660

0.84

0.98

3.5

3.2

—

Obsessive-compulsive disorder

175

0.57

0.98

5.0

3.1

—

Decubitus ulcer and pressure area

0.00

0.97

0.0

3.0

—

Other diseases of pancreas

0.00

0.97

0.0

2.7

—

Nonorganic sleeping disorders

308

0.68

0.97

2.8

3.2

—

Arthropathies in other diseases classified elsewhere

0.00

0.97

0.0

3.5

—

Hypotension

0.00

0.97

0.0

2.9

—

Diseases of peritoneum

1.95

0.97

3.1

2.8

—

Malignant melanoma, including Hilmo

1.95

0.97

2.3

3.1

—

Early syphilis

0.00

0.96

0.0

2.7

—

Asthma and allergy

303

0.68

0.96

2.6

3.2

—

Early syphilis

0.00

0.95

0.0

2.8

—

Childhood allergy (age < 16)

553

0.79

0.95

3.2

3.0

—

Suppurative and necrotic conditions of lower respiratory tract

0.00

0.95

0.0

2.9

—

Asthma and allergy, excluding more controls

302

0.69

0.95

2.6

3.2

—

Soft tissue disorders related to use, overuse and pressure

173

0.58

0.94

4.3

3.0

—

Pure hypercholesterolaemia

314

0.75

0.94

3.5

3.1

—

Phobic anxiety disorders

340

0.70

0.94

2.7

3.1

—

Other congenital malformations of skin

1.90

0.94

2.3

2.7

—

Other diseases of upper respiratory tract

143

862

0.86

0.94

3.3

3.1

—

Disorders of vitreous body and globe

166

0.58

0.94

3.1

3.0

—

Asthma, hospital admission 2, infections

731

0.80

0.94

2.8

3.2

—

Asthma-related infections

731

0.80

0.94

2.8

3.2

—

Nonalcoholic fatty liver disease

118

0.51

0.93

3.8

2.9

—

Generalized skin eruption due to drugs and medicaments

2.23

0.93

1.3

2.5

—

Osteonecrosis

2.23

0.93

1.7

2.8

—

Other diseases of the digestive system

197

0.61

0.93

3.1

2.9

—

Psoriatic and enteropathic arthropathies

120

0.50

0.93

2.5

3.1

—

Persons encountering health services for examination and investigation

116

683

0.85

0.92

3.1

3.2

—

Disorders of skin appendages

743

0.81

0.91

3.2

3.1

—

Unspecified kidney failure

2.14

0.91

2.3

2.8

—

Malignant melanoma of skin, including Hilmo

2.14

0.91

2.5

3.2

—

Hypogonadotropic hypogonadism

102

1.58

0.90

2.4

3.1

—

Striking against or struck by other objects

862

0.82

0.90

2.9

3.1

—

Excessive earwax

463

0.76

0.90

3.4

3.1

—

ILD medications: azathioprine

290

0.69

0.89

3.1

3.0

—

Acute generalized exanthematous pustulosis

2.07

0.89

1.3

2.5

—

Aortic aneurysm

1.66

0.89

4.2

2.9

—

Pneumonia, organism unspecified

111

910

0.85

0.89

2.8

3.2

—

Disorders of lacrimal system

218

0.64

0.89

2.8

—

Acute laryngitis and tracheitis

454

0.76

0.88

3.7

3.1

—

Additional codes for the location of defect, injury or illness

1.91

0.88

3.8

3.0

—

Major coronary heart disease event excluding revascularizations

122

0.60

0.88

3.8

2.7

—

Azathioprine

289

0.69

0.88

3.1

3.0

—

Other infectious diseases

1.79

0.87

2.2

3.0

—

Extrapyramidal and movement disorders

156

0.58

0.87

3.6

2.8

—

Diseases of the digestive system

345

0.72

0.87

3.5

3.0

—

Infections of the skin and subcutaneous tissue

1033

0.84

0.86

2.9

3.2

—

Other reaction to severe stress, and adjustment disorders

616

0.79

0.86

3.6

3.2

—

Suppurative and unspecified otitis media

953

0.85

0.86

3.0

3.2

—

Other infectious diseases

1.82

0.85

2.3

3.2

—

Any gastric operation

186

825

1.13

0.85

2.6

3.3

—

GASTRO-related operations

186

825

1.13

0.85

2.6

3.3

—

Acute peritonitis

1.94

0.84

3.5

2.8

—

Intestinal adhesions without obstruction

1.94

0.84

3.5

3.0

—

Crohn disease

239

0.67

0.84

3.3

3.1

—

Other enthesopathies

179

0.61

0.84

2.8

3.0

—

Other predominantly sexually transmitted diseases, not elsewhere classified

442

1.25

0.84

2.8

3.3

—

Hypoplasia of dental enamel , including avohilmo

1.77

0.83

2.4

2.1

—

Gout

0.53

0.83

2.7

3.1

—

Bronchitis, not specified as acute or chronic

114

0.53

0.82

3.0

3.1

—

Other disorders involving the immune mechanism, not elsewhere classified

1.74

0.82

2.1

2.7

—

Somatoform disorder

141

0.57

0.82

2.8

2.9

—

Injuries to the hip and thigh

423

0.77

0.82

2.4

3.2

—

Molar incisor enamel hypoplasia

1.72

0.81

2.4

2.1

—

Cardiovascular diseases

158

962

0.88

0.81

3.2

3.1

—

Other congenital malformations

172

1.40

0.80

3.0

—

Generalized anxiety disorder

283

0.71

0.80

3.4

3.2

—

Acne conglobata

0.00

0.79

0.0

2.9

—

Mental and behavioural disorders due to hallucinogens

0.00

0.79

0.0

3.0

—

Clubfoot

0.00

0.79

0.0

2.8

—

Atrial septal defect, secundum type

0.00

0.79

0.0

2.1

—

Lichen simplex chronicus

0.00

0.79

0.0

3.0

—

Mandibular prognathia

0.00

0.79

0.0

2.7

—

0.00

0.79

0.0

3.2

—

Other diseases of spinal cord

0.00

0.79

0.0

2.8

—

Radial styloid tenosynovitis [de Quervain]

0.00

0.79

0.0

2.4

—

Amputation of toe

0.00

0.79

0.0

3.2

—

Acute gastritis

0.00

0.79

0.0

2.8

—

Provisional assignment of new diseases of uncertain etiology

585

0.80

0.78

2.8

3.2

—

Codes for special purposes

585

0.80

0.78

2.8

3.2

—

Viral pneumonia (known virus, not influenza)

0.00

0.78

0.0

2.7

—

Behavioural disorders, excluding more controls

0.52

0.78

3.2

2.7

—

Migraine with aura

223

0.67

0.78

3.9

3.1

—

Early onset COPD, excluding more controls

0.52

0.78

2.8

2.9

—

Early onset COPD

0.51

0.77

2.8

2.7

—

Ingrowing nail

0.50

0.77

2.0

3.0

—

Disorders of muscles

0.50

0.77

2.4

2.9

—

Other disorders of adrenal gland

0.00

0.77

0.0

2.8

—

Injuries to the knee and lower leg

195

969

1.12

0.76

3.4

3.1

—

Injuries to the elbow and forearm

962

0.86

0.76

3.1

—

Hydrocele

157

1.40

0.76

2.8

2.9

—

Paroxysmal tachycardia

176

0.67

0.76

3.0

2.8

—

Renal failure

227

0.70

0.76

2.3

3.0

—

Fracture of skull and facial bones

527

0.80

0.75

3.5

3.3

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1.64

0.75

1.6

2.8

—

Malignant neoplasm of endocrine gland

2.09

0.74

2.4

3.0

—

Other cataract

103

0.59

0.74

1.9

3.0

—

COPD/asthma/ILD related infections

137

779

0.88

0.74

3.3

3.1

—

COPD/asthma related infections

137

779

0.88

0.74

3.3

3.1

—

Disorders of vitreous body

155

0.62

0.74

3.1

3.0

—

Fever of other and unknown origin

587

1.18

0.74

2.6

3.2

—

Disturbances of skin sensation

245

1.31

0.73

3.3

3.2

—

Malignant neoplasm of digestive organs

1.61

0.73

4.1

3.4

—

Car occupant injured in other and unspecified transport accidents

357

0.76

0.73

3.2

—

Non-ischemic cardiomyopathy

0.54

0.73

4.7

2.9

—

Assault

491

0.79

0.73

3.0

3.3

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

138

0.64

0.73

2.8

3.0

—

Other dialysis

2.00

0.72

3.8

3.0

—

Other follicular disorders

108

0.55

0.72

7.5

2.9

—

Emotional disorders starting during childhood or adolescence

109

0.54

0.72

3.8

2.6

—

Non-selective monoamine reuptake inhibitors

165

0.64

0.72

1.9

2.9

—

Other nutritional deficiencies

524

0.81

0.71

2.9

3.2

—

Injuries to the ankle and foot

135

1061

1.13

0.71

3.1

3.2

—

In situ neoplasms

1.92

0.70

2.2

2.7

—

Open wound of forearm

170

0.65

0.70

3.3

3.1

—

Acute upper respiratory infections of multiple and unspecified sites

132

864

1.13

0.70

3.0

3.1

—

Diaphragmatic hernia

143

0.63

0.69

2.3

3.0

—

Vasomotor and allergic rhinitis

661

0.83

0.69

3.4

3.1

—

All chronic kidney diseases

390

0.80

0.69

2.8

3.2

—

Falls/tendency to fall

169

943

0.90

0.68

3.3

3.1

—

Other and unspecified mononeuropathies of upper limb

1.86

0.68

6.0

3.1

—

Other diseases of hard tissues of teeth

428

1.16

0.68

2.9

3.3

—

Benign neoplasm: Parotid gland

1.85

0.68

3.2

2.7

—

Separation of retinal layers (serosa)

1.67

0.68

4.3

2.8

—

Diseases of the eye and adnexa

162

906

0.90

0.68

3.5

3.1

—

GI-bleeding

204

0.69

0.68

3.2

2.9

—

Other disorders of penis

227

0.70

0.68

2.3

2.9

—

Foreign body on external eye

386

0.78

0.68

3.2

—

Fracture of femur

142

0.64

0.67

2.3

3.1

—

Disorders of continuity of bone

120

0.58

0.67

3.6

3.0

—

Injuries to the wrist and hand

158

980

1.12

0.67

2.9

3.2

—

Coxarthrosis, primary, with hip surgery

1.64

0.67

2.1

2.5

—

Glucagon-like peptide-1 (GLP-1) analogues

156

0.64

0.67

2.0

2.9

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

156

0.64

0.67

2.0

2.9

—

First line medication for Crohn's disease

170

1021

0.90

0.67

2.9

3.2

—

Benign neoplasm of bone and articular cartilage

0.55

0.67

5.0

3.0

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

1.63

0.67

2.1

2.5

—

Conduct disorder

0.53

0.67

3.2

2.6

—

Injury of muscle and tendon at lower leg level

203

0.69

0.66

4.1

3.0

—

Enterocolitis due to Clostridium difficile

1.63

0.66

1.4

3.0

—

Benign neoplasm: Colon, unspecified

1.63

0.66

3.1

3.0

—

Asthma-related pneumonia

317

0.76

0.66

2.6

3.1

—

Thyrotoxicosis, other and/or unspecified

0.54

0.66

2.4

3.1

—

Demyelinating diseases of the central nervous system

0.53

0.66

1.4

3.0

—

Heartburn

0.53

0.66

2.6

3.3

—

Benign neoplasm: salivary glands, exclude unknown (D119)

1.79

0.66

3.2

2.8

—

Thyrotoxicosis

0.53

0.66

2.4

3.0

—

Other viral diseases

501

1.19

0.66

3.0

3.1

—

Atopic dermatitis, strict definition with reimbursement

466

0.81

0.64

3.2

3.1

—

Deforming dorsopathies

236

0.72

0.64

4.4

3.1

—

Deep bite

112

0.63

0.64

1.6

2.5

—

Injuries to the neck

349

0.77

0.64

2.8

3.2

—

Benign neoplasm of colon, rectum, anus and anal canal

185

0.70

0.64

2.7

3.0

—

Preparatory care for dialysis

1.73

0.64

3.4

3.0

—

Myeloproliferative diseases

1.73

0.64

3.4

2.8

—

Malignant melanoma

1.72

0.64

2.6

3.3

—

Allergic rhinitis

595

0.83

0.63

3.6

3.1

—

Fracture of lumbar spine and pelvis

127

0.63

3.4

2.9

—

Pain in thoracic spine

130

0.61

0.63

3.0

3.2

—

Any reimbursement code in KELA

142

796

0.89

0.63

2.8

3.3

—

Crowding of teeth, including avohilmo

137

0.66

0.63

2.1

2.4

—

Congenital malformations, deformations and chromosomal abnormalities

123

1041

1.13

0.63

3.1

3.2

—

Infectious mononucleosis

225

1.29

0.63

3.2

3.0

—

Other benign neoplasms of skin

181

1.33

0.63

2.7

3.0

—

Effects of other external causes

101

0.59

0.62

3.8

3.0

—

Convergent concomitant strabismus

102

0.59

0.62

2.7

3.0

—

Tonsillectomy and adenotomy

155

971

1.11

0.62

3.3

3.1

—

Gout, FINNGEN

101

0.59

0.62

2.7

—

Complications of procedures, not elsewhere classified

622

0.85

0.61

2.5

3.4

—

Pain (limb, back, neck, head abdominally)

138

773

0.89

0.61

2.9

3.2

—

Atopic dermatitis, strict definition

448

0.81

0.61

3.2

3.0

—

Viral infections characterized by skin and mucous membrane lesions

101

979

0.88

0.61

3.2

3.1

—

Glucosamine medication

0.00

0.61

0.0

2.9

—

Disease of hard tissues of teeth, NOS

428

0.86

0.60

3.5

3.3

—

Burn and corrosion of ankle and foot

0.00

0.60

0.0

2.9

—

Ankylosing spondylitis, ICD10

138

0.65

0.60

2.6

3.0

—

Other disorders of pigmentation

0.00

0.60

0.0

3.4

—

Right ventricular outflow tract obstruction

0.00

0.60

0.0

2.7

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

0.00

0.60

0.0

2.7

—

Charcot foot

0.00

0.60

0.0

3.7

—

Viral encephalitis, not elsewhere classified/unspecified

0.00

0.60

0.0

2.9

—

Endocarditis

0.00

0.60

0.0

3.0

—

Disorders of calcium metabolism

0.00

0.60

0.0

2.9

—

Other disorders of nervous system

0.00

0.60

0.0

3.1

—

Cardiac arrest

0.00

0.60

0.0

3.2

—

Social phobias

255

0.74

0.60

2.4

3.1

—

Viral infections characterized by skin and mucous membrane lesions

433

0.81

0.59

3.4

3.2

—

Caries in Clefts patients

0.00

0.59

0.0

2.7

—

Hypothermia

0.00

0.59

0.0

3.0

—

Pyothorax

0.00

0.59

0.0

2.9

—

Fibromyalgia

0.00

0.59

0.0

2.7

—

Obesity and other hyperalimentation

491

0.82

0.59

2.8

3.2

—

Diseases of the ear and mastoid process

176

972

0.91

0.59

3.3

3.1

—

Varicose veins of other sites

157

1.34

0.59

3.2

3.1

—

Pectus excavatum

0.00

0.58

0.0

3.0

—

Suppurative otitis media, unspecified

1.57

0.58

3.2

2.6

—

Enthesopathies of lower limb, excluding foot

197

0.71

0.58

2.5

3.2

—

Adrenocortical insufficiency

0.00

0.58

0.0

3.1

—

Amiodarone users

0.00

0.58

0.0

2.7

—

Bacterial pneumonia (organism specified)

372

0.80

0.58

3.0

3.1

—

Retinal detachments and breaks

112

0.62

0.58

1.6

2.9

—

Other and unspecified nerve root and plexus disorders, also in other diseases

185

0.70

0.58

4.5

3.0

—

Viral pneumonia (unknown virus, not influenza)

114

0.61

0.58

1.9

3.0

—

Other and unspecified injuries of lower leg

114

0.61

0.58

3.4

2.9

—

Helminthiases

1.72

0.57

2.8

2.7

—

Dialysis, with operation codes

123

1.38

0.57

2.5

3.0

—

Other specified/unspecified bacterial intestinal infections

1.72

0.57

5.8

3.3

—

Acne

320

0.78

0.57

2.7

3.1

—

Open wound of wrist and hand

967

0.88

0.57

3.1

3.2

—

Obesity

489

0.83

0.57

2.8

3.2

—

Hydrocephalus

1.67

0.56

2.8

3.0

—

Myocarditis

0.57

0.56

3.4

3.1

—

Other shoulder lesions

0.57

0.56

6.0

3.1

—

Burns and corrosions

252

0.75

0.56

2.8

3.0

—

Combinations of oral blood glucose lowering drugs

0.57

0.56

3.0

—

Diplopia

0.57

0.56

1.4

3.1

—

Covid-19 suspected case

330

0.79

0.55

2.7

3.0

—

Abnormal results of function studies

0.55

4.4

2.9

—

Open wound of ankle and foot

183

0.71

0.55

3.2

3.1

—

Anxiety disorders

137

1056

0.90

0.55

3.3

3.1

—

Dental pulpitis, including avohilmo

146

1045

0.91

0.55

3.2

3.1

—

Behavioural syndromes associated with physiological disturbances and physical factors

135

1059

0.90

0.54

3.0

3.2

—

Fracture of forearm

679

0.86

0.54

3.2

3.0

—

Sequelae of injuries, of poisoning and of other consequences of external causes

362

0.80

0.54

3.1

3.3

—

Asthma, hospital admissions 3, pneumonia

317

0.79

0.54

2.6

3.1

—

Asthma-related pneumonia or sepsis

317

0.79

0.54

2.6

3.1

—

Diabetic retinopathy, excluding more controls

0.60

0.54

2.3

—

Other coagulation defects

1.58

0.54

1.2

3.0

—

Bacterial intestinal infections, IBD co-morbidities

116

1.38

0.54

3.4

3.0

—

Osteopathies and chondropathies

439

0.83

0.54

2.6

3.2

—

Contraceptive management

1.48

0.53

1.8

1.9

—

Myocardial infarction

0.67

0.53

3.7

3.0

—

Cysts of oral region, not elsewhere classified

1.52

0.52

5.7

2.7

—

Transient ischemic attack

109

0.67

0.52

2.9

—

Neurotic, stress-related and somatoform disorders

137

1056

0.91

0.52

3.3

3.1

—

Acne vulgaris

282

0.78

0.52

2.9

3.1

—

Post-traumatic stress disorder

0.62

0.52

2.0

2.8

—

Glomerulonephritis

0.62

0.52

2.8

3.0

—

Allergic urticaria

0.61

0.51

5.2

2.9

—

Viral pneumonia

169

0.71

0.51

2.1

3.2

—

Other metabolic disorders

1.45

0.51

2.0

2.7

—

Urethral stricture

1.50

0.51

2.7

2.8

—

Desensitization to allergens

135

0.67

0.51

3.6

2.8

—

Bell's palsy

100

0.60

0.51

3.5

3.1

—

Dizziness and giddiness

406

0.84

0.51

3.3

3.2

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

154

0.70

0.50

3.2

3.1

—

Cough

328

0.81

0.50

4.0

3.0

—

Disorders of tooth development and eruption

359

1.17

0.50

3.7

3.2

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

597

0.88

0.50

2.5

3.2

—

Obesity due to excess calories

368

0.81

0.49

2.6

3.1

—

Caught, crushed, jammed or pinched in or between objects

107

0.65

0.48

4.0

3.1

—

Chronic sinusitis

464

0.84

0.48

3.5

3.3

—

Crohn's disease NAS

110

0.64

0.48

3.3

3.0

—

Cholecystectomy

212

0.77

0.48

3.6

3.0

—

Dermatophytosis

110

0.64

0.48

2.7

3.2

—

Disorders of speech understanding and production

109

0.63

0.48

3.6

2.6

—

Use of disulfiram, acamprosate or naltrexone

166

0.72

0.47

4.0

2.8

—

Haemorrhoids and perianal venous thrombosis

188

0.74

0.47

4.1

2.9

—

Pollen allergy

435

0.84

0.46

3.5

3.0

—

Mycoses

132

1048

1.10

0.46

3.2

—

Eustachian salpingitis and obstruction

221

0.77

0.46

4.5

3.4

—

Neuromuscular dysfunction of bladder

1.43

0.46

2.7

3.1

—

Other symptoms and signs involving the circulatory and respiratory systems

0.62

0.45

2.2

3.1

—

Ulcerative rectosigmoiditis

117

0.68

0.45

4.4

2.9

—

MS-disease / Multiple Sclerosis

0.60

0.45

1.4

3.0

—

Gout, idiopatic and unspecified

0.60

0.45

3.0

2.9

—

Cervicalgia

119

0.67

0.45

4.0

3.1

—

Behavioural disorders

0.59

0.45

3.2

2.5

—

Cardiac murmurs and other cardiac sounds

119

0.66

0.45

2.3

2.5

—

Struck by thrown, projected or falling objec

121

0.66

0.45

4.4

3.1

—

Diseases of salivary glands

265

0.79

0.45

3.6

3.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

388

1.17

0.45

2.2

3.2

—

Contact with sharp object, undetermined intent

1.40

0.45

2.1

2.8

—

Coxarthrosis, primary

1.43

0.45

2.4

2.7

—

Acute bronchiolitis

115

0.70

0.43

3.0

2.1

—

Nausea and vomiting

247

0.79

0.43

2.8

3.0

—

Infections with a predominantly sexual mode of transmission

825

1.11

0.43

3.0

3.2

—

Benign neoplasm of major salivary glands

1.61

0.43

3.2

2.7

—

Pleural effusion

1.61

0.43

1.8

2.6

—

Ankylosing spondylitis

131

0.69

0.43

2.6

3.3

—

Burns and corrosions of external body surface, specified by site

196

0.76

0.42

3.1

2.9

—

Otitis externa, unspecified

113

1.33

0.42

2.5

2.8

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

546

1.14

0.42

3.3

3.2

—

Need for other prophylactic measures

0.66

0.42

1.2

2.8

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.66

0.42

4.0

3.0

—

Other/unspecified synovitis and tenosynovitis

0.64

0.42

3.3

3.1

—

Nephropathy related operations

122

1.31

0.42

2.6

2.9

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

814

0.89

0.42

3.1

—

Seborrhoeic dermatitis

0.63

0.42

2.0

2.9

—

Recurrent aphthous stomatitis , including avohilmo

131

1.30

0.42

3.1

2.8

—

150

840

0.92

0.42

3.2

3.1

—

Bacterial Sepsis

252

0.81

0.41

2.9

3.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

322

0.83

0.41

2.5

3.2

—

Dermatophytosis

897

1.10

0.41

3.3

3.1

—

Klinefelter syndrome, karyotype 47 XXY

0.00

0.41

0.0

3.1

—

Other congenital malformations of male genital organs

1.52

0.41

2.0

2.5

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

1.38

0.41

2.5

2.9

—

Exposure to ignition of highly flammable material

0.00

0.41

0.0

3.0

—

Evidence of alcohol involvement determined by level of intoxication

0.00

0.41

0.0

2.7

—

Implicit bacterial Sepsis

173

0.77

0.41

2.6

2.9

—

Immunodeficiencies

1.52

0.41

2.6

2.7

—

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

0.00

0.41

0.0

3.7

—

Personal history of certain other diseases

0.00

0.41

0.0

2.1

—

Sequelae of intentional self-harm, assault and events of undetermined intent

0.00

0.41

0.0

2.4

—

Sixth [abducent] nerve palsy

0.00

0.41

0.0

2.6

—

Cleft lip and cleft lip and palate

0.00

0.41

0.0

2.7

—

Oral lichen planus, including avohilmo , including avohilmo

0.00

0.41

0.0

2.8

—

Fibrosis and cirrhosis of liver

0.00

0.41

0.0

2.7

—

Retinal vascular disorders

0.00

0.41

0.0

3.4

—

Acute and subacute iridocyclitis

206

0.78

0.41

3.2

3.1

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

552

0.87

0.41

3.1

3.2

—

Whooping cough

0.00

0.41

0.0

2.8

—

Guttate psoriasis

0.00

0.41

0.0

3.2

—

Acute epiglottitis

0.00

0.41

0.0

3.6

—

Secondary parkinsonism, excluding more controls

0.00

0.41

0.0

3.5

—

Oesophageal varices

0.00

0.41

0.0

3.2

—

Pustulosis palmaris et plantaris

0.00

0.41

0.0

3.6

—

Calcific tendinitis of shoulder

0.00

0.41

0.0

3.3

—

Other and unspecified syphilis

0.00

0.41

0.0

2.5

—

Benign neoplasm of mouth and pharynx

1.36

0.41

4.1

2.7

—

Focal epilepsy, strict definition

231

1.21

0.41

2.0

3.1

—

Diabetic retinopathy

0.68

0.41

2.3

2.6

—

Synovial hypertrophy, not elsewhere classified

0.00

0.40

0.0

3.1

—

Toxic effect of alcohol

0.00

0.40

0.0

2.6

—

Other specified/unspecified disorders of bone/cartilage

0.00

0.40

0.0

3.0

—

Conotruncal defects

1.48

0.40

5.0

2.3

—

IgA nephropathy (IgA glomerulonephritis)

1.47

0.40

2.4

2.7

—

Diving or jumping into water causing injury other than drowning or submersion

0.00

0.40

0.0

3.3

—

Injury of muscle and tendon at shoulder and upper arm level

194

0.77

0.40

3.3

3.0

—

Fissure and fistula of anal and rectal regions

271

0.81

0.40

2.5

3.0

—

Epidural haemorrhage

0.00

0.40

0.0

2.6

—

Tularaemia

0.00

0.40

0.0

3.3

—

Secondary polycythaemia

0.00

0.40

0.0

3.2

—

Other specified disorders of muscle

0.00

0.40

0.0

2.8

—

Extreme obesity with alveolar hypoventilation

0.00

0.40

0.0

2.9

—

Ulcer of oesophagus

0.00

0.40

0.0

2.8

—

Acute appendicitis, with complications

159

1.26

0.40

3.4

2.9

—

Other hammer toe(s) (acquired)

0.00

0.40

0.0

2.9

—

Other disorders of cornea

101

0.69

0.39

2.7

3.1

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

470

0.86

0.39

3.5

3.2

—

Ankylosing spondylitis, strict definition

104

0.67

0.39

2.3

2.9

—

Post-traumatic wound infection, not elsewhere classified

1.43

0.39

2.8

3.4

—

Hyperfunction of pituitary gland

1.43

0.39

4.0

2.6

—

Opioids

194

941

1.07

0.39

2.8

3.3

—

Other diseases caused by chlamydiae

0.00

0.39

0.0

2.8

—

Other and unspecified nail disorders

0.00

0.39

0.0

3.4

—

Pustular psoriasis

0.00

0.39

0.0

3.6

—

Other peripheral vertigo

0.00

0.39

0.0

3.0

—

Cardiomyopathy

106

0.66

0.39

3.0

2.9

—

Acute pharyngitis

300

0.83

0.39

2.7

3.1

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.41

0.39

3.6

2.6

—

Specific development disorders of scholastic skills

190

0.78

0.38

2.3

3.0

—

Kidney transplant status

1.37

0.38

2.8

3.0

—

General symptoms and signs

198

928

1.07

0.38

3.0

3.2

—

Seborrhoeic keratosis

1.39

0.38

3.2

2.7

—

Hypothyroidism, drug reimbursement

0.69

0.37

3.1

—

Varicose veins

0.70

0.37

3.1

2.9

—

Bacterial pneumonia, not elsewhere classified

313

0.84

0.37

2.7

3.1

—

Abnormal findings on diagnostic imaging of lung

154

1.24

0.37

1.8

2.9

—

Disorders of other endocrine glands

412

0.86

0.37

2.5

3.2

—

Infections, IBD-co-morbidities

192

0.82

0.37

3.3

3.2

—

Other benign neoplasms of connective and other soft tissue

1.29

0.36

3.0

2.8

—

Anterior Iridocyclitis

213

0.80

0.36

3.1

—

Complications of medical and surgical care

482

1.13

0.36

2.3

3.3

—

Other/unspecified enthesopathies of lower limb, excluding foot

1.27

0.36

3.0

3.3

—

Bacterial pneumoniae

340

0.86

0.36

3.0

3.2

—

Superficial injury of head

353

0.85

0.36

3.0

3.2

—

Bronchitis

163

958

1.07

0.35

3.0

3.2

—

Juvenile arthritis (FINNGEN)

0.66

0.35

3.0

2.7

—

Contact with heat and hot substances

0.65

0.35

5.0

2.8

—

Heterophoria

0.66

0.35

5.0

2.5

—

Pilonidal cyst

299

0.84

0.35

2.7

3.2

—

Lateral epicondylitis

0.64

0.35

3.8

3.0

—

Exclusion endpoint for clefts

1.43

0.35

4.3

2.5

—

Other disorders of optic [2nd] nerve and visual pathways

1.43

0.35

1.5

2.9

—

Thrombocytopenia, unspecified

1.43

0.35

2.3

2.8

—

Other juvenile arthritis

0.63

0.35

3.0

2.9

—

Benign neoplasm: Skin of eyelid, including canthus

1.43

0.35

2.5

3.0

—

Herpesviral [herpes simplex] infections

0.63

0.35

4.4

3.1

—

Other or unspecified ileus, impaction or obstruction

0.63

0.35

4.2

2.8

—

Mixed disorders of conduct and emotions, excluding more controls

123

0.73

0.35

3.7

2.8

—

Crohn's disease of small intestine

123

0.73

0.35

2.6

2.9

—

Other viral diseases

664

1.11

0.35

3.2

3.1

—

Other congenital malformations

126

1.27

0.35

2.5

2.8

—

Abnormal serum enzyme levels

123

0.71

0.35

2.1

2.8

—

Paracetamol or NSAID medication

283

1.12

0.34

2.5

3.0

—

Diseases of inner ear

257

0.83

0.34

4.0

2.9

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

167

0.78

0.34

2.5

3.1

—

Hallux valgus (acquired)

1.35

0.34

3.0

2.9

—

Acute nasopharyngitis (common cold)

231

0.82

0.34

2.7

3.1

—

Focal epilepsy

255

1.18

0.34

2.4

3.1

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

1.33

0.33

3.2

3.0

—

Sudden idiopathic hearing loss

1.33

0.33

2.5

3.0

—

Nummular dermatitis

1.30

0.33

2.2

2.7

—

Ulcerative proctitis

0.68

0.33

3.7

2.9

—

Diseases of the respiratory system

101

550

0.92

0.33

2.7

3.2

—

Scoliosis

0.67

0.33

4.5

3.1

—

Gingivitis and periodontal diseases

162

783

1.07

0.32

3.3

3.1

—

Acute upper respiratory infections

150

864

1.07

0.32

3.2

3.1

—

Hydronephrosis

1.28

0.32

2.5

2.9

—

Hypopituitarism

155

1.23

0.32

2.3

2.9

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

143

0.77

0.32

3.5

3.1

—

Sequelae of injuries of upper limb

143

0.77

0.32

3.3

3.0

—

Acute tubulo-interstitial nephritis

199

0.82

0.31

2.2

2.9

—

Anti-inflammatory and antirheumatic products, non-steroids

371

1.10

0.31

2.9

—

Open wound of lower leg

219

0.82

0.31

2.3

2.9

—

Symptoms and signs involving the skin and subcutaneous tissue

567

1.10

0.31

3.0

3.2

—

Caries of dentine

338

0.86

0.31

2.3

3.3

—

Fracture of foot, except ankle

411

0.88

0.31

3.3

3.1

—

Other and unspecified drugs and medicaments

1.32

0.30

2.7

2.8

—

Sequelae of external causes of morbidity and mortality

186

0.81

0.30

2.3

3.0

—

Bacterial, viral and other infectious agents

131

0.76

0.30

4.2

2.9

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

142

0.77

0.30

2.5

3.0

—

Anomalies of dental arch relationship, including avohilmo

236

0.84

0.30

2.8

—

Other keratitis

164

0.79

0.30

3.3

3.1

—

Superficial injury of forearm

153

0.78

0.30

2.8

—

Myocardial infarction, without ST-elevation

1.30

0.30

4.0

2.7

—

Other and unspecified disorders of vitreous body

1.30

0.30

2.3

3.0

—

Other orthopaedic follow-up care

1.30

0.30

3.6

3.1

—

Hypermetropia

1.30

0.30

4.3

2.6

—

Corneal ulcer

293

0.85

0.30

3.4

3.2

—

Unspecified acute lower respiratory infection

196

0.82

0.29

1.9

3.0

—

Iridocyclitis

239

0.84

0.29

2.9

3.0

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

130

0.77

0.29

4.4

2.9

—

Acute renal failure

106

0.75

0.29

1.9

3.0

—

Chronic diseases of tonsils and adenoids

145

861

1.06

0.29

3.4

3.1

—

Myocardial infarction, strict

0.75

0.28

3.7

3.0

—

Aortic valve malfunction, age under 60 years

118

0.76

0.27

4.8

2.9

—

Dysphagia

118

0.76

0.27

2.9

3.1

—

Persons encountering health services in other circumstances, wide

182

987

0.95

0.27

3.0

3.2

—

Other bacterial intestinal infections

122

1.23

0.27

3.5

2.8

—

Other diseases of blood and blood-forming organs, wide

159

1.20

0.26

3.1

—

Benign neoplasm: Colon

143

0.80

0.26

2.7

3.0

—

Influenza and pneumonia

155

1041

0.95

0.26

2.7

3.2

—

Congenital malformations and deformations of the musculoskeletal system

181

0.82

0.26

2.9

—

Gastrointestinal diseases

133

708

0.94

0.26

3.2

—

Acute lymphadenitis

1.26

0.26

3.6

3.0

—

6-mercaptopurine

1.28

0.26

2.4

2.9

—

Other disorders of eyelid

0.69

0.26

5.0

2.9

—

Postprocedural disorders of nervous system

0.69

0.26

5.2

2.9

—

Lung diseases due to external agents

0.68

0.26

2.2

3.1

—

Other respiratory disorders and diseases

0.68

0.26

2.8

3.0

—

Other diseases of the respiratory system

0.68

0.26

2.8

3.0

—

Other endocrine disorders

0.67

0.26

3.4

2.6

—

Other disorders of the musculoskeletal system and connective tissue

0.68

0.26

2.0

3.0

—

Conductive hearing loss, unspecified

0.67

0.25

4.2

2.9

—

Orchitis and epididymitis

197

1.17

0.25

2.9

3.0

—

Cervical disc disorders

149

0.81

0.25

3.9

3.3

—

Rheumatoid arthritis, including avohilmo

149

0.81

0.25

5.0

3.0

—

D07AA Corticosteroids, weak (group I)

224

0.85

0.25

3.7

3.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

121

779

0.94

0.25

2.9

3.1

—

121

779

0.94

0.25

2.9

3.1

—

Open bite

1.25

0.25

3.7

2.6

—

Chondropathies

192

0.83

0.25

3.0

3.1

—

Subjective visual disturbances

192

0.83

0.25

4.4

3.0

—

Ganglion

181

0.83

0.25

4.9

3.2

—

Acute appendicitis, no complications

857

0.93

0.25

2.9

3.3

—

Mycoses

213

0.84

0.25

3.3

3.0

—

Recurrent dislocation and subluxation of joint

159

0.82

0.24

2.5

3.1

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

226

1.15

0.24

2.2

3.1

—

Contusion of other and unspecified parts of foot

1.25

0.24

2.5

2.8

—

Intestinal stricture

142

1.20

0.24

3.6

3.0

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

0.73

0.24

4.5

2.8

—

Congenital malformations of the urinary system

0.73

0.24

2.8

—

Methotrexate

0.73

0.24

3.2

3.0

—

Other disorders of male genital organs

124

1.21

0.24

2.5

2.9

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

267

0.87

0.24

3.8

3.0

—

Spondylolisthesis/Spondylolysis

0.71

0.24

3.0

3.4

—

Symptoms and signs involving the digestive system and abdomen

181

951

0.95

0.23

2.9

3.2

—

Pneumococcal septicemia

1.32

0.23

4.6

2.9

—

Crohn disease (strict definition, require KELA)

136

0.81

0.23

3.5

3.1

—

Pneumonia derived septicemia

1.28

0.23

4.6

3.0

—

Fracture of shoulder and upper arm

485

1.09

0.22

2.9

3.1

—

Spinal stenosis

0.75

0.22

1.3

3.3

—

Candidiasis

162

1.17

0.22

2.7

3.0

—

Any death

212

0.88

0.22

2.8

2.9

—

Aplastic and other anaemias

151

1.17

0.22

2.8

2.9

—

Colonic or urogenital fistula

253

0.87

0.22

2.5

3.0

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

266

1.13

0.22

2.7

3.0

—

Other inflammation of eyelid

0.77

0.22

4.1

3.1

—

Impingement syndrome of shoulder

0.77

0.22

4.0

2.9

—

Oedema, not elsewhere classified

160

1.17

0.22

3.3

3.0

—

Superficial injury of shoulder and upper arm

157

0.83

0.22

3.9

2.9

—

Follicular cysts of skin and subcutaneous tissue

221

0.86

0.22

3.3

3.1

—

Dislocation, sprain and strain of joints and ligaments of elbow

0.74

0.22

3.4

2.6

—

Care involving dialysis

1.27

0.22

2.6

3.3

—

Other/unspecified dorsalgia

344

0.89

0.22

2.3

3.4

—

Hypospadias with an incomplete glans penis

0.00

0.21

0.0

2.0

—

Toxic effect of organic solvents

0.00

0.21

0.0

2.5

—

Injury of nerves and spinal cord at thorax level

0.00

0.21

0.0

3.9

—

Superficial injury of ankle and foot, unspecified

0.00

0.21

0.0

3.0

—

Juvenile Open Angle Glaucoma

0.00

0.21

0.0

3.2

—

Asymptomatic human immunodeficiency virus [HIV] infection status

0.00

0.21

0.0

3.1

—

Osteochondrosis of ankle, juvenile

0.00

0.21

0.0

2.0

—

Precocious central puberty

0.00

0.21

0.0

3.9

—

Fall involving playground equipment

0.00

0.21

0.0

2.0

—

Congenital malformations of pulmonary and tricuspid valves

0.00

0.21

0.0

2.7

—

Congenital obstruction of the pelviureteric junction

0.00

0.21

0.0

2.8

—

Other congenital malformations, not elsewhere classified

0.00

0.21

0.0

2.5

—

Postviral fatigue syndrome

0.00

0.21

0.0

2.9

—

Impacted maxillary canine

0.00

0.21

0.0

1.6

—

Benign intracranial hypertension

0.00

0.21

0.0

2.7

—

Intracranial and intraspinal abscess and granuloma

0.00

0.21

0.0

2.7

—

0.00

0.21

0.0

2.6

—

Tularaemia

0.00

0.21

0.0

3.1

—

Arthropathy in ulcerative colitis

0.00

0.21

0.0

2.8

—

Dental operations

477

0.94

0.21

3.0

3.2

—

Unspecified visual impairment (binocular)

0.00

0.21

0.0

2.6

—

Eosinophilia

0.00

0.21

0.0

3.2

—

Disorders of iron metabolism

0.00

0.21

0.0

2.9

—

Peroneal tendinitis

0.00

0.21

0.0

3.6

—

Type 1 diabetes, wide definition, subgroup 2

0.00

0.21

0.0

2.6

—

Iridocyclitis in diseases classified elsewhere

0.00

0.21

0.0

3.5

—

Communicating hydrocephalus

0.00

0.21

0.0

2.1

—

Disorders of globe

0.00

0.21

0.0

2.8

—

Secondary parkinsonism

0.00

0.21

0.0

2.6

—

Other bullous disorders

0.00

0.21

0.0

2.3

—

Small fibre neuropathy

0.00

0.21

0.0

3.2

—

Secondary parkinsonism+Parkinsonism in other disease

0.00

0.21

0.0

2.6

—

Other facial nerve disorders

0.00

0.21

0.0

2.6

—

Other and unspecified mononeuropathies, also in other diseases

0.00

0.21

0.0

2.5

—

Peripheral retinal degeneration

0.00

0.21

0.0

3.3

—

Postprocedural disorders of digestive system, not elsewhere classified

0.00

0.21

0.0

3.1

—

SLE (Finngen)

0.00

0.21

0.0

2.8

—

Other deformities of toe(s)

0.00

0.21

0.0

3.1

—

Bulimia nervosa (incl. atypical)

0.00

0.21

0.0

3.6

—

Gluteal tendinitis

0.00

0.21

0.0

3.8

—

Attention to artificial openings

0.00

0.21

0.0

2.2

—

Fungal Sepsis

0.00

0.21

0.0

3.4

—

Hypercalcemia

0.00

0.21

0.0

1.9

—

Cirrhosis of liver, NAS

0.00

0.21

0.0

3.3

—

Benign neoplasm: Choroid

0.00

0.21

0.0

3.2

—

Special screening examination for neoplasms

0.00

0.21

0.0

3.5

—

Unspecified transport accident

0.00

0.21

0.0

3.6

—

Mandibular prognathia AND surgery (LeFortI or BSSO)

0.00

0.21

0.0

3.4

—

Cleft lip and palate

0.00

0.21

0.0

3.2

—

Other congenital malformations of heart

0.00

0.21

0.0

2.0

—

Pedal cyclist injured in transport accident

382

1.10

0.21

3.1

3.2

—

Contact with venomous snakes and lizards

0.00

0.21

0.0

3.3

—

Previous suicide attempt

0.00

0.21

0.0

2.8

—

Pyogenic granuloma

0.00

0.21

0.0

2.1

—

Endocrine disorders, other/unspecified

0.00

0.21

0.0

2.7

—

Fourth [trochlear] nerve palsy

0.00

0.21

0.0

3.3

—

Erythema nodosum

0.00

0.21

0.0

3.0

—

Benign neoplasm: Conjunctiva

0.00

0.21

0.0

2.1

—

Postprocedural musculoskeletal disorders, not elsewhere classified

0.00

0.21

0.0

2.7

—

Benign neoplasm: Adrenal gland

0.00

0.21

0.0

3.1

—

Other and unspecified vascular occlusions

0.00

0.21

0.0

3.2

—

Hallux rigidus

0.00

0.21

0.0

3.1

—

Episcleritis

1.16

0.21

4.2

3.2

—

Benign neoplasm of middle ear and respiratory system

1.16

0.21

3.0

2.8

—

Mental and behavioural disorders due to use of volatile solvents

0.00

0.21

0.0

2.9

—

Supernumerary teeth EXCLUDE clefts and syndromes

0.00

0.21

0.0

2.7

—

Moderate mental retardation

0.00

0.21

0.0

2.4

—

Whooping cough

0.00

0.21

0.0

2.5

—

Congenital stenosis of pulmonary valve

0.00

0.21

0.0

2.9

—

Burns classified according to extent of body surface involved

0.00

0.21

0.0

3.1

—

Other specified and unspecified strabismus

0.00

0.21

0.0

2.4

—

Other injuries of upper limb, level unspecified

0.00

0.21

0.0

3.2

—

Guillain-Barre syndrome

0.00

0.21

0.0

2.9

—

Trigeminal neuralgia

0.00

0.21

0.0

2.8

—

Endovascular or surgical operations to intracerebral aneurysms

0.00

0.21

0.0

3.0

—

COPD-related respiratory insufficiency

0.00

0.21

0.0

3.5

—

Benign lipomatous neoplasm

177

0.85

0.21

3.8

3.0

—

Congenital malformations and deformations of the musculoskeletal system

218

0.87

0.20

2.9

—

Viral warts

134

0.82

0.20

3.1

2.8

—

Other maltreatment syndromes

117

1.20

0.20

2.3

3.1

—

145

1.17

0.20

2.5

3.0

—

Nondiabetic hypoglycaemic coma

0.00

0.20

0.0

3.0

—

Complex cardiac defects

0.00

0.20

0.0

2.9

—

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.20

0.0

2.7

—

Stomatitis and related lesions

240

0.87

0.20

3.2

3.0

—

Exposure to unspecified smoke, fire and flames

0.00

0.20

0.0

3.1

—

Exposure to excessive natural cold

0.00

0.20

0.0

3.4

—

Migraine without aura, drug-induced

0.00

0.20

0.0

3.1

—

Benign neoplasm: Spinal cord

0.00

0.20

0.0

3.0

—

Certolizumab pegol

0.00

0.20

0.0

3.4

—

Granulomatous disorders of skin and subcutaneous tissue

0.00

0.20

0.0

2.4

—

Myositis

0.00

0.20

0.0

3.4

—

Bullous disorders

0.00

0.20

0.0

2.1

—

Retinal vascular occlusion

0.00

0.20

0.0

3.5

—

Blepharochalasis

0.00

0.20

0.0

2.8

—

Radiculopathy

1.22

0.20

2.5

3.5

—

Personal history of other diseases and conditions

1.22

0.20

3.3

2.7

—

Phlebitis and thrombophlebitis (not including DVT)

114

0.79

0.20

2.3

3.0

—

Chronic periodontitis, complicated

320

0.90

0.19

3.0

3.1

—

Foreign body or object entering through skin

133

0.83

0.19

2.9

—

Other pulmonary diagnosis

140

669

1.05

0.19

3.1

3.2

—

Excluding asthma or asthma-COPD overlap

140

669

1.05

0.19

3.1

3.2

—

Peritonsillar abscess

406

0.91

0.19

3.1

3.2

—

Other and unspecified urticaria

186

0.86

0.19

2.4

2.9

—

Tinnitus

154

0.84

0.19

4.8

3.0

—

Nonsuppurative otitis media

643

1.06

0.19

3.1

—

Aneurysms, operations, SAH

1.13

0.18

1.2

3.1

—

Disorders of vestibular function (Vertigo)

172

0.86

0.18

3.9

2.9

—

Atopic dermatitis

103

888

0.95

0.18

3.2

3.1

—

Sequelae of injuries of lower limb

132

0.83

0.18

3.4

3.2

—

Unspecified privation

128

1.17

0.18

3.8

2.9

—

Impotence

1.19

0.18

2.3

3.1

—

Other complications of surgical and medical care, not elsewhere classified

1.17

0.17

1.9

3.1

—

Family history of malignant neoplasm

1.17

0.17

3.6

3.1

—

Other embolism and thrombosis

1.15

0.17

1.7

3.2

—

Congenital malformations of the circulatory system

217

1.12

0.17

3.6

2.9

—

Contusion of ankle

0.76

0.17

2.6

2.8

—

Other disorders of kidney and ureter

0.76

0.17

1.8

2.8

—

Injury of unspecified body region

0.75

0.17

4.0

2.8

—

Diabetic retinopathy, strict definition

0.72

0.17

2.4

2.6

—

Nontraumatic intracranial haemmorrhage

0.75

0.17

1.2

2.9

—

Etanercept

0.72

0.17

2.8

3.0

—

Other and unspecified effects of external causes

454

0.92

0.16

3.4

3.2

—

Pain associated with micturition

0.71

0.16

1.6

2.8

—

Other skin changes

0.71

0.16

3.4

3.1

—

Fibroblastic disorders

0.71

0.16

2.2

3.0

—

All influenza

369

1.08

0.16

2.7

3.3

—

Disorders of sclera, cornea, iris and ciliary body

731

0.94

0.16

3.1

3.2

—

Obesity, other/unspecified

246

0.89

0.16

3.0

2.9

—

Spondylosis

158

0.88

0.16

2.2

3.2

—

Crohn disease (strict definition, require KELA, min 2 HDR)

130

0.85

0.16

3.5

3.1

—

Other spirochaetal diseases

214

0.89

0.15

3.9

3.0

—

Abdominal and pelvic pain

183

951

0.97

0.15

2.9

3.2

—

Non-allergic asthma

1.10

0.15

3.1

2.6

—

Foreign body entering into or through eye or natural orifice

168

1.13

0.15

4.3

3.2

—

Propionic acid derivatives

371

1.06

0.15

2.8

2.9

—

Disorders of conjunctiva

123

1028

0.96

0.15

3.6

3.1

—

Caries of dentine, including avohilmo

107

572

0.96

0.15

2.7

3.3

—

Congenital malformations of the urinary system

0.76

0.15

2.8

2.6

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

114

547

1.05

0.15

2.8

3.3

—

Coxarthrosis [arthrosis of hip](FG)

1.15

0.15

2.6

3.0

—

L04AD Calcineurin inhibitors

159

1.13

0.15

3.2

2.9

—

Glomerular disorders in diseases classified elsewhere

121

1.16

0.15

2.5

3.1

—

COPD differential diagnosis

138

665

1.04

0.15

3.1

3.2

—

Malignant neoplasm of skin

0.81

0.15

4.4

3.0

—

ILD differential diagnosis

138

665

1.04

0.15

3.1

3.2

—

Other disorders of bone

213

0.89

0.15

2.8

3.0

—

Candidiasis

1.08

0.14

3.4

3.1

—

Crohn's disease of large intestine

0.79

0.14

4.1

3.0

—

Fall on same level involving ice and snow

645

0.95

0.14

3.4

3.1

—

Crossbite

0.82

0.13

3.0

2.4

—

Coeliac disease

0.81

0.13

4.0

2.9

—

Injury of muscle and tendon at hip and thigh level

100

0.80

0.13

1.4

3.1

—

Diseases of appendix

103

966

0.96

0.13

3.0

3.2

—

Diseases of pulp and periapical tissues and dental caries

482

0.96

0.13

3.1

3.3

—

Mixed disorders of conduct and emotions

108

0.83

0.13

3.7

2.8

—

Any operation in hilmo

131

1.09

0.13

3.0

3.5

—

Bacterial, viral and other infectious agents

138

0.87

0.13

4.1

2.9

—

Injuries to unspecified part of trunk, limb or body region

108

0.83

0.13

2.8

2.9

—

Localized swelling, mass and lump of skin and subcutaneous tissue

238

1.09

0.13

2.0

3.0

—

Redundant prepuce, phimosis and paraphimosis

738

1.05

0.13

3.1

2.9

—

Contact with other sharp object(s)

161

1.12

0.13

3.2

3.1

—

Functional dyspepsia

161

1.12

0.13

4.4

3.0

—

Sequelae with surgical and medical care as external cause

104

1.15

0.12

2.5

3.0

—

Other headache syndromes

354

0.93

0.12

2.8

3.3

—

Maltreatment syndromes

158

0.89

0.12

4.2

3.1

—

External causes of morbidity and mortality

113

546

1.04

0.12

3.2

3.1

—

Systemic connective tissue disorders

114

1.14

0.11

3.2

3.1

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

131

0.90

0.11

3.6

3.0

—

Appendicitis, broad definition

103

965

0.97

0.11

3.0

3.2

—

Herpesviral [herpes simplex] infections

209

0.91

0.11

3.5

3.0

—

Spirochaetal infections, other/unspecified

209

0.91

0.11

3.9

3.0

—

Paralytic ileus and intestinal obstruction

124

1.13

0.11

3.6

2.8

—

Embedded teeth, including avohilmo

219

0.91

0.11

2.6

3.1

—

All influenza (not pneumonia)

291

0.93

0.11

3.0

3.2

—

Myalgia

198

0.91

0.10

2.4

3.2

—

Unspecified haematuria

224

0.92

0.10

2.3

3.0

—

Exposure to other and unspecified inanimate mechanical forces

146

0.89

0.10

2.2

2.9

—

Fracture at wrist and hand level

889

0.97

0.10

3.1

3.2

—

Other spirochaetal diseases

218

0.92

0.10

3.9

3.0

—

Foreign body in respiratory tract

1.14

0.10

6.2

3.1

—

Otalgia

1.14

0.10

4.0

2.8

—

Accidents

120

619

0.97

0.09

3.2

3.1

—

Rosacea

1.06

0.09

4.8

2.9

—

DVT of lower extremities and pulmonary embolism

154

1.10

0.09

2.9

—

Appendectomy

956

0.97

0.09

2.9

3.2

—

Erosion of teeth , including avohilmo

409

1.05

0.09

2.1

3.2

—

Viral meningitis

1.11

0.09

2.2

2.9

—

Injuries to the head

161

1012

0.98

0.09

3.0

3.2

—

Lyme disease

206

0.92

0.08

3.9

3.0

—

Calculus of kidney and ureter

204

1.08

0.08

3.6

3.0

—

Diabetic nephropathy

1.06

0.08

5.2

2.4

—

Tooth agenesis EXCLUDE clefts and syndromes

1.05

0.08

2.0

2.6

—

Other/unspecified reactive arthropathies

1.05

0.08

3.3

2.9

—

Thyroiditis, ILD-related definition

1.05

0.08

2.5

2.9

—

Motorcycle rider injured in other and unspecified transport accidents

214

1.08

0.08

2.3

3.0

—

Explicit Sepsis

259

0.94

0.08

2.5

2.9

—

Polypectomy (DHB20)

0.82

0.08

2.2

3.0

—

Nonischemic cardiomyopathy

0.78

0.08

5.2

3.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

178

987

0.98

0.08

3.0

3.2

—

Dental caries, including avohilmo

516

0.97

0.08

2.9

3.3

—

Pediculosis, acariasis and other infestations

1.09

0.08

2.6

—

Misadventures to patients during surgical and medical care

1.08

0.08

2.4

3.1

—

Burn and corrosion of wrist and hand

1.06

0.08

3.9

3.1

—

Cluster headache, strict, including avohilmo

1.03

0.07

2.3

2.9

—

Sequelae of other and unspecified infectious and parasitic diseases

1.03

0.07

3.1

—

Sequelae of infectious and parasitic diseases

1.03

0.07

3.1

—

Disorders in reading

0.83

0.07

3.7

2.6

—

Impacted maxillary molar

133

0.90

0.07

5.3

2.9

—

Gastroduodenal ulcer

0.80

0.07

4.2

3.1

—

Injury of nerves at wrist and hand level

1.08

0.07

2.6

3.0

—

Reactive arthropathies, FINNGEN

1.08

0.07

3.1

3.0

—

Certain infectious and parasitic diseases

163

800

1.02

0.07

3.2

—

Other hearing loss

1.04

0.07

2.1

2.9

—

Early lumbar disc prolapse, operated

235

0.94

0.07

4.7

3.4

—

Congenital malformations of heart and great arteries

198

0.93

0.07

4.0

2.9

—

Chalazion

112

0.89

0.07

2.9

—

Congenital malformations of aortic and mitral valves

0.86

0.07

5.6

3.0

—

Hernia of abdominal wall, postoperative

0.83

0.07

1.7

3.0

—

Disorders of optic nerve and visual pathways

1.05

0.07

1.6

3.0

—

Congenital malformations of cardiac septa

1.01

0.06

4.4

2.5

—

Secondary hypertension

0.86

0.06

2.3

3.3

—

Left ventricular outflow tract obstruction, narrow definition

0.85

0.06

5.3

2.9

—

Other diseases of anus and rectum

193

0.93

0.06

3.3

2.9

—

Other disorders of eye and adnexa

128

1.09

0.06

2.9

3.0

—

Cardiodefibrillation

100

0.90

0.06

3.2

3.0

—

Chronic suppurative otitis media

104

0.86

0.06

2.7

2.8

—

Chronic kidney disease

149

0.92

0.06

2.5

2.9

—

Chronic rhinitis, nasopharyngitis and pharyngitis

335

1.04

0.06

3.7

3.1

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

121

0.91

0.06

2.5

3.1

—

Venous thromboembolism

225

0.94

0.05

2.9

3.1

—

Other septicaemia

228

1.05

0.05

2.6

3.0

—

Monoamine oxidase A inhibitors

1.11

0.05

2.2

3.1

—

Bitten or struck by other mammals

120

1.08

0.04

3.5

2.9

—

Polyuria

120

1.08

0.04

2.5

3.1

—

Abrasion of teeth

199

1.06

0.04

2.6

3.0

—

Symptoms and signs involving speech and voice

150

0.93

0.04

4.9

2.8

—

Injuries to the shoulder and upper arm

130

1062

0.99

0.04

3.3

3.1

—

Voice disturbances

109

0.92

0.04

5.3

2.9

—

Other viral diseases, not elsewhere classified

420

0.97

0.04

3.1

3.2

—

Melanocytic naevi

279

1.04

0.04

2.8

3.2

—

Injury, poisoning and certain other consequences of external causes

453

1.02

0.04

3.3

3.1

—

Acute appendicitis

100

949

0.98

0.03

3.0

3.2

—

Other superficial mycoses

210

1.05

0.03

3.1

—

Acute sinusitis

763

0.98

0.03

3.5

3.2

—

Non-allergic asthma (mode)

169

1.05

0.03

2.6

3.1

—

Other external causes of accidental injury

122

619

0.99

0.03

3.2

3.1

—

Zoster [herpes zoster]

1.09

0.03

2.5

3.0

—

Epilepsy

418

1.03

0.03

2.4

3.3

—

Septicaemia

271

0.97

0.03

2.5

3.0

—

Keratitis

491

0.98

0.03

3.4

3.2

—

Pulmonary embolism

102

1.08

0.03

3.1

3.0

—

Pulmonary heart disease

102

1.08

0.03

3.1

3.0

—

Fall on and from stairs and steps

209

0.96

0.03

3.4

2.9

—

Chronic suppurative otitis media, including avohilmo

108

0.93

0.03

2.9

2.8

—

Contact with sharp glass

112

1.07

0.03

3.6

2.9

—

Non-allergic asthma (mode), excluding more controls

170

1.05

0.02

2.6

3.0

—

Anogenital herpesviral [herpes simplex] infection

117

0.94

0.01

2.8

3.2

—

Temporomandibular joint disorders, including avohilmo

416

1.02

0.01

3.3

3.2

—

Noninfectious colitis NAS

167

0.96

0.01

2.5

2.9

—

Pedal cyclist injured in other and unspecified transport accidents

173

1.04

0.01

3.3

3.0

—

Glomerular diseases

187

0.96

0.01

2.4

3.0

—

Viral infections of the central nervous system

106

0.94

0.01

2.9

3.0

—

Testicular dysfunction

116

0.95

0.00

2.2

3.1

—

Pulmonary heart disease, diseases of pulmonary circulation

104

1.06

0.00

3.1

3.0

—

Dental caries

381

0.98

0.00

2.2

3.3

—

Superficial injury of hip and thigh

124

1.05

0.00

2.4

3.0

—

Certain disorders involving the immune mechanism

176

0.97

0.00

2.5

2.9

—

Other diseases of pleura

170

1.03

0.00

2.4

2.8

—

Other and unspecified anaemias

128

1.04

0.00

2.5

3.0

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

348

1.00

0.00

2.1

3.2

—

Other anaemias

130

1.02

0.00

2.5

2.9

—

Coxarthrosis

102

1.04

0.00

2.6

3.1

—

Excessive attrition of teeth

665

1.01

0.00

3.3

3.2

—

Adverse effects, not elsewhere classified

187

1.02

0.00

2.9

3.1

—

Other gastritis (incl. Duodenitis)

104

0.96

0.00

1.5

3.0

—

Superficial injury of lower leg

337

1.01

0.00

3.3

3.1

—

Speech therapy

134

0.97

0.00

2.9

3.0

—

Other viral diseases, not elsewhere classified

259

1.00

0.00

2.8

2.9

—

Dislocation, sprain and strain of joints and ligaments at neck level

224

0.98

0.00

2.9

3.1

—

Viral Sepsis

145

0.97

0.00

2.4

2.9

—

Certain conditions originating in the perinatal period

171

0.99

0.00

2.2

2.8

—

Purpura and other haemorrhagic conditions

118

1.02

0.00

2.4

2.9

—

Coagulation defects, purpura and other haemorrhagic conditions

155

1.03

0.00

2.1

2.9

—

Superficial injury of ankle and foot

235

0.98

0.00

2.8

3.2

—

Other disorders of veins

118

1.01

0.00

3.3

2.9

—

Otitis externa

221

1.00

0.00

2.5

2.9

—

Other local infections of skin and subcutaneous tissue

104

0.96

0.00

2.2

3.1

—

Urolithiasis

216

1.02

0.00

3.6

3.0

—

Torsion of testis

123

0.98

0.00

2.8

2.9

—

Tooth eruption problems

336

0.99

0.00

2.6

3.1

—

Pedal cyclist injured in noncollision transport accidents

197

1.02

0.00

3.8

3.0

—

Early lumbar disc prolapse operation

253

0.99

0.00

4.6

3.1

—

Umbilical hernia

178

1.01

0.00

3.2

2.8

—

Superficial injury of abdomen, lower back and pelvis

222

0.99

0.00

3.0

—

Conjunctivitis

120

1004

1.00

0.00

3.7

3.1

—

Pain, not elsewhere classified

280

1.00

0.00

3.2

3.4

—

Other and unspecified local infections of skin and subcutaneous tissue

101

0.99

0.00

2.2

3.1

—

Testicular hypofunction

1.01

0.00

1.8

3.0

—

Diseases of external ear

295

0.98

0.00

3.1

2.9

—

Viral infections of the central nervous system

110

1.00

0.00

2.7

3.0

—

Hernia of abdominal wall

262

0.99

0.00

3.9

3.0

—

Implicit viral Sepsis

144

0.97

0.00

2.4

3.0

—

L04AA Selective immunosuppressants

249

1.00

0.00

2.6

3.0

—

Exclusions for E4_PCOS_BROAD

216

1.02

0.00

2.8

2.9

—

Reactive arthropathies

1.03

0.00

3.6

3.3

—

Abscess of anal and rectal regions

173

0.98

0.00

2.9

3.0

—

Motorcycle rider injured in noncollision transport accidents

1.05

0.00

3.2

2.9

—

Pyoderma

0.00

0.0

3.0

—

Exposure to other specified electric current

0.97

0.00

3.8

3.0

—

Other appendicitis

0.93

0.00

4.1

2.9

—

Atrioventricular septal defect

0.00

0.0

3.0

—

Urticaria due to cold and heat

0.00

0.0

2.1

—

Abnormal findings in nipple discharge synovial fluid wound secretions

0.00

0.0

2.8

—

Other specified and unspecified disorders of eyelid

0.00

0.0

1.9

—

Hypoparathyroidism

0.00

0.0

1.4

—

Eosinophilic disease (BM)

0.00

0.0

4.0

—

Osteoporosis

0.93

0.00

1.6

3.1

—

Other localized connective tissue disorders

0.00

0.0

2.6

—

Unspecified chronic bronchitis

0.00

0.0

1.9

—

Meralgia paraesthetica

0.00

0.0

3.3

—

Perichondritis of external ear

0.00

0.0

2.2

—

Maxillary prognathism

0.00

0.0

2.5

—

SLE, ICD10

0.00

0.0

3.1

—

Use of glatiramer acetate

0.00

0.0

3.5

—

Acute posthaemorrhagic anaemia

0.00

0.0

3.4

—

Macular pucker

0.00

0.0

3.0

—

Hypertrophy of (infrapatellar) fat pad

0.00

0.0

2.8

—

Congenital ichthyosis

0.00

0.0

3.3

—

Faecal incontinence

0.00

0.0

2.3

—

SLE, strict definition

0.00

0.0

3.1

—

Exfoliative dermatitis

0.00

0.0

3.0

—

Bruxism

0.00

0.0

3.7

—

Other specified disorders of kidney and ureter

0.00

0.0

2.9

—

Hypocalcemia

0.00

0.0

1.6

—

Symptoms and signs involving appearance and behaviour

0.00

0.0

1.8

—

Primary angle-closure glaucoma

0.00

0.0

2.2

—

Toxic effect of corrosive substances

0.00

0.0

3.0

—

Fall involving bed

0.00

0.0

3.1

—

Injury of nerves at shoulder and upper arm level

0.00

0.0

2.9

—

Traction detachment of retina

0.00

0.0

2.7

—

Meningococcal infection

0.00

0.0

3.4

—

Diabetes insipidus

0.00

0.0

2.6

—

Contact with other and unspecified heat and hot substances

0.00

0.0

2.2

—

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

0.00

0.0

2.7

—

Hereditary spherocytosis

0.00

-0.00

0.0

3.0

—

Nonhereditary hypogammaglobulinemia

0.00

-0.00

0.0

3.1

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

-0.00

0.0

1.0

—

Benign paroxysmal vertigo

0.99

-0.00

4.4

3.1

—

Scleritis

0.00

-0.00

0.0

2.0

—

Melanocytic naevi of lip

0.00

-0.00

0.0

1.8

—

Benign neoplasm of urinary organs

0.00

-0.00

0.0

2.6

—

Benign neoplasm: Skin of lip

0.00

-0.00

0.0

2.0

—

Diabetic nephropathy, excluding more controls

0.93

-0.00

5.2

2.4

—

Benign neoplasm: Scrotum

0.00

-0.00

0.0

4.2

—

Other or unspecified paralytic strabismus

0.00

-0.00

0.0

3.2

—

Other bursal cyst

0.00

-0.00

0.0

2.8

—

Haemangioma and lymphangioma, any site

0.89

-0.00

4.6

2.8

—

Other hereditary haemolytic anaemias

0.00

-0.00

0.0

3.0

—

Type 1 diabetes, strict definition, subgroup 2

0.00

-0.00

0.0

2.5

—

Dermatitis herpetiformis

0.00

-0.00

0.0

2.3

—

Benign neoplasm: Bone and articular cartilage, unspecified

0.00

-0.00

0.0

2.8

—

Infection due to other mycobacteria

0.00

-0.00

0.0

3.0

—

Systemic lupus erythematosus

0.00

-0.00

0.0

3.1

—

Embolic stroke

0.00

-0.00

0.0

3.3

—

Pedestrian injured in other and unspecified transport accidents

0.00

-0.00

0.0

3.3

—

Benign neoplasm: Short bones of lower limb

0.00

-0.00

0.0

3.0

—

Benign neoplasm: Lip

0.00

-0.00

0.0

2.6

—

Other factor of the environment

0.00

-0.00

0.0

3.0

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

0.00

-0.00

0.0

3.2

—

Inguinal hernia, bilateral

0.86

-0.00

2.4

3.2

—

Benign neoplasm: Brain, infratentorial

0.00

-0.00

0.0

1.5

—

Anoxic brain damage

0.00

-0.00

0.0

3.0

—

Abscess of lung

0.00

-0.00

0.0

3.9

—

Portal vein thrombosis

0.00

-0.00

0.0

2.3

—

Other and unspecified injuries of neck

0.00

-0.00

0.0

3.1

—

Brain meningioma

0.00

-0.00

0.0

3.0

—

Acute alcohol intoxication ICD-9

0.00

-0.00

0.0

3.4

—

Other osteochondropathies

0.98

-0.00

1.9

2.9

—

Abnormal findings on diagnostic imaging of other body structures

1.00

-0.00

3.8

3.1

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

0.89

-0.00

3.9

2.6

—

Explosion of other materials

0.00

-0.00

0.0

1.6

—

Septal defects

0.96

-0.00

3.6

2.6

—

Lifestyle-related condition

0.00

-0.00

0.0

3.4

—

Frostbite with tissue necrosis

0.00

-0.00

0.0

1.7

—

Autoimmune hepatitis

0.00

-0.00

0.0

2.5

—

Use of anticholinesterases

0.00

-0.00

0.0

3.4

—

Amputation of foot

0.00

-0.00

0.0

2.2

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

0.00

-0.00

0.0

1.3

—

Other and unspecified injuries of ankle and foot

0.93

-0.00

4.7

2.8

—

Chronic gastritis

0.93

-0.00

2.2

3.3

—

Implicit fungal Sepsis

0.00

-0.00

0.0

4.0

—

Other and unspecified syphilis

0.00

-0.00

0.0

2.8

—

Hypertrophy of tongue papillae

0.00

-0.00

0.0

3.4

—

Scabies

0.94

-0.00

1.6

2.8

—

Amputation of ankle bones

0.00

-0.00

0.0

2.3

—

Contact with hot air and gases

0.00

-0.00

0.0

4.2

—

DVT of lower extremities

0.93

-0.00

2.6

3.1

—

Single ventricle heart

0.00

-0.00

0.0

2.4

—

Tetraplegia

0.00

-0.00

0.0

3.3

—

Contact with hypodermic needle

0.00

-0.00

0.0

2.2

—

Toxic effect of other gases, fumes and vapours

0.00

-0.00

0.0

2.5

—

Crohn disease (strict definition, all UC cases excluded)

0.98

-0.00

2.3

2.9

—

Other congenital malformations of upper alimentary tract

0.00

-0.00

0.0

2.0

—

Alcoholic gastritis

0.00

-0.00

0.0

4.0

—

Acquired absence of organs, not elsewhere classified

0.00

-0.00

0.0

3.9

—

Infection of intervertebral disc (pyogenic)

0.00

-0.00

0.0

3.0

—

Abnormal involuntary movements

0.91

-0.00

2.6

2.8

—

Other congenital malformations of brain

0.00

-0.00

0.0

3.1

—

Poisoning by medicine, drug-induced

0.00

-0.00

0.0

2.2

—

Early complications of trauma

0.88

-0.00

2.5

3.1

—

Multiple myeloma and malignant plasma cell neoplasms

0.00

-0.00

0.0

3.0

—

N06DA Anticholinesterases

0.00

-0.00

0.0

3.4

—

Left bundle-branch block

0.00

-0.00

0.0

3.0

—

Polyarthrosis

0.00

-0.00

0.0

2.9

—

Ventral hernia

0.96

-0.00

4.9

2.9

—

Viral warts

350

1.00

-0.00

3.0

—

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

0.00

-0.00

0.0

3.4

—

Other and unspecified injuries of wrist and hand

0.92

-0.00

5.5

2.4

—

Follow-up care involving plastic surgery

0.00

-0.00

0.0

3.8

—

Diabetic maculopathy

0.96

-0.00

3.7

2.5

—

Acidosis

0.00

-0.00

0.0

2.6

—

Atrophic disorders of skin

0.94

-0.00

2.9

2.8

—

Other congenital malformations of nervous system

0.00

-0.00

0.0

3.7

—

Reiter disease

0.00

-0.00

0.0

3.4

—

Acute myringitis

0.00

-0.00

0.0

1.7

—

!Aliquae complicationes praecoces traumatis

0.88

-0.00

2.5

3.1

—

Cauda equina syndrome

0.00

-0.00

0.0

3.0

—

Oral lichen planus

0.00

-0.00

0.0

2.2

—

Benign neoplasm: Connective and other soft tissue, unspecified

0.00

-0.00

0.0

2.8

—

Localized scleroderma [morphea]

0.00

-0.00

0.0

2.6

—

Late syphilis

0.00

-0.00

0.0

2.9

—

Fetus and newborn affected by maternal complications of pregnancy

0.00

-0.00

0.0

1.0

—

Juvenile osteochondrosis

1.01

-0.00

4.9

2.6

—

Striae atrophicae

0.00

-0.00

0.0

2.7

—

Explicit bacterial Sepsis

0.91

-0.00

3.4

3.0

—

Shigellosis

0.00

-0.00

0.0

2.2

—

Anogenital herpesviral [herpes simplex] infection

0.88

-0.00

2.3

3.2

—

Rubella [German measles]

0.00

-0.00

0.0

2.1

—

Discitis, unspecified

0.00

-0.00

0.0

4.6

—

Event of undetermined intent

140

1.00

-0.00

2.0

3.2

—

Varus deformity, not elsewhere classified

0.00

-0.00

0.0

2.7

—

Benign neoplasm: Descending colon

0.00

-0.00

0.0

4.1

—

Primary adrenocortical insufficiency

0.00

-0.00

0.0

1.7

—

Pneumothorax

0.89

-0.00

2.3

2.8

—

Nail dystrophy

0.00

-0.00

0.0

1.8

—

Cluster headache, wide,, including avohilmo

0.99

-0.00

2.3

2.9

—

Blindness, monocular

0.00

-0.00

0.0

4.1

—

Inguinal or femoral hernia, bilateral

0.86

-0.00

2.4

3.2

—

Disorders of brain, other and unspecified

0.00

-0.00

0.0

4.0

—

Other acute disseminated demyelination

0.00

-0.00

0.0

2.3

—

Mitochondrial myopathy

0.00

-0.00

0.0

2.9

—

Cleft lip

0.00

-0.00

0.0

2.1

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

0.00

-0.00

0.0

2.2

—

Narcolepsy and cataplexy

0.00

-0.00

0.0

3.1

—

Cushing syndrome

0.00

-0.00

0.0

1.6

—

Iron deficiency

0.00

-0.00

0.0

2.7

—

Other abnormalities of plasma proteins

0.00

-0.00

0.0

2.5

—

Occupant of pick-up truck or van injured in other and unspecified transport accidents

0.00

-0.00

0.0

2.7

—

Other lesions of median nerve

0.00

-0.00

0.0

2.4

—

Vascular disorders of the intestines

0.00

-0.00

0.0

2.7

—

Traumatic amputation of part of head

0.00

-0.00

0.0

2.8

—

Fall on and from ladder

0.86

-0.00

3.4

2.9

—

Brain meningioma, including Hilmo

0.00

-0.00

0.0

3.0

—

Rifle, shotgun and larger firearm discharge

0.00

-0.00

0.0

2.7

—

Hypersomnia

0.00

-0.00

0.0

2.7

—

Physiological and behavioural disorders associated with sexual development and orientation

0.00

-0.00

0.0

2.6

—

Kela-code for behavioural disturbances in mental retardation

0.00

-0.00

0.0

3.5

—

Agoraphobia

0.95

-0.00

4.7

2.8

—

Glaucoma-related operations

0.00

-0.00

0.0

2.3

—

Other specified/unspecified nutritional deficiencies

0.00

-0.00

0.0

3.0

—

Use of dimethyl fumarate

0.00

-0.00

0.0

1.6

—

Anosmia

0.00

-0.00

0.0

4.0

—

Bilateral cryptorchidism (undescended testicles)

0.00

-0.00

0.0

1.3

—

Short stature starting before birth

0.00

-0.00

0.0

3.2

—

Epileptic seizures related to drugs

0.00

-0.00

0.0

3.1

—

Habit and impulse disorders

0.85

-0.00

6.0

2.7

—

Unspecified protein-energy malnutrition

0.00

-0.00

0.0

1.2

—

Other and unspecified degenerative diseases of nervous system

0.00

-0.00

0.0

1.6

—

Discontinuity and dislocation of ear ossicles

0.00

-0.00

0.0

2.6

—

Otorrhagia

0.00

-0.00

0.0

3.4

—

Other abnormal findings in urine

0.00

-0.00

0.0

2.8

—

Sequelae of transport accidents

0.00

-0.00

0.0

2.7

—

Exposure to uncontrolled fire in building or structure

0.00

-0.00

0.0

3.7

—

Migraine with aura, drug-induced

0.00

-0.00

0.0

2.9

—

Polyglandular dysfunction

0.00

-0.00

0.0

1.2

—

Malnutrition

0.00

-0.00

0.0

1.9

—

Cellulitis of external ear

0.00

-0.00

0.0

2.2

—

Precocious puberty

0.00

-0.00

0.0

2.8

—

Other proliferative retinopathy

0.00

-0.00

0.0

2.7

—

Open wound of abdomen, lower back and pelvis

0.98

-0.00

5.7

2.9

—

Multiple myeloma, including Hilmo

0.00

-0.00

0.0

3.2

—

Other lack of coordination

0.00

-0.00

0.0

3.1

—

Other and unspecified iridocyclitis

0.96

-0.00

2.2

3.0

—

Hordeolum and other deep inflammation of eyelid

0.91

-0.00

3.4

3.0

—

Down's syndrome

0.00

-0.00

0.0

1.9

—

Ocular pain

0.91

-0.00

1.8

2.7

—

Sacrococcygeal disorders, not elsewhere classified

0.00

-0.00

0.0

3.7

—

Dementia in other diseases classified elsewhere

0.00

-0.00

0.0

2.6

—

Generalized epilepsy

0.87

-0.00

4.2

2.8

—

Scleritis and episcleritis

1.02

-0.00

4.2

3.1

—

Impacted cerumen

0.88

-0.00

3.6

2.6

—

Total colectomy operation

0.86

-0.00

3.2

3.0

—

Acute mastoiditis

0.00

-0.00

0.0

1.1

—

Other or ill-defined heart diseases

0.91

-0.00

3.0

—

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

0.00

-0.00

0.0

3.8

—

Colectomy operation

1.01

-0.00

3.7

3.0

—

Congenital malformations of eye, ear, face and neck

0.91

-0.00

3.9

2.7

—

Malignant neoplasm of pancreas, including Hilmo

0.00

-0.00

0.0

3.6

—

Total colectomy

0.86

-0.00

3.2

3.0

—

Bicuspidal aortic valve syndrome

0.92

-0.00

4.5

3.0

—

Other and unspecified hypertrophic disorders of skin

0.00

-0.00

0.0

3.0

—

Other specified and unspecified disorders of conjunctiva

0.00

-0.00

0.0

1.7

—

Cervicocranial syndrome

0.94

-0.00

3.2

—

Aspergillosis

0.00

-0.00

0.0

3.8

—

Injury of nerves at ankle and foot level

0.00

-0.00

0.0

2.7

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

0.00

-0.00

0.0

2.1

—

Other abnormal auditory perceptions

0.00

-0.00

0.0

2.5

—

Benign neoplasm of thyroid gland

0.00

-0.00

0.0

3.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Spermatozoa Progressive [#/volume] in Semen

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS